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Due to low yield, the venom of Aipysurus eydouxii (Marbled sea snake) snake has not 
been extensively studied. However, partial cDNA library of A. eydouxii venom gland 
was constructed by our lab, which revealed the presence of few novel proteins. One of 
them showed no sequence similarity with any sequence in the database, but had a long 
open reading frame. The deduced protein sequence contained 113 amino acid residues 
with a 19-residue signal peptide at the N-terminal and the mature protein of 94 amino 
acid residues including 6 cysteine residues. Since these clones encode a cysteine-rich, 
secreted protein similar to most proteins in snake venoms, we were intrigued to 
understand its structure and function.  
In this study, we describe the recombinant expression, purification, folding and 
characterization of inflamin, the first member of a novel family of snake venom 
proteins. Inflamin was expressed in E. coli cells followed by affinity chromatography 
and reverse phase chromatography. Protein was refolded using redox buffer and 
finally purified by reverse phase chromatography. Inflamin has I-III, II-IV and V-VI 
disulfide bonds as determined by partial reduction and cyanylation method. When 
injected into mice at various doses, all of them showed writhing responses, a 
pharmacological symptom of pain, but none of the mice died within 24 h. 
Indomethacin suppressed inflamin-induced writhing. Intraplantar injection induced 
inflammation and edema in rat paws.  
The peritoneal exudate showed the dose-dependent increase in prostanoids. Levels of 
prostanoids (6-keto PGF1α, PGE2, PGD2, PGF2α and TXB2) peaked at 10 min 
following inflamin injection that corresponded well to the peak of writhing responses. 
Interestingly, the increase in the level of 6-keto PGF1α was highest among all the 
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prostanoids at 10 min indicating that most of the PGH2 liberated by cyclooxygenase 
enzyme is shunted towards prostacyclin synthase enzyme. Later, second wave of 
prostanoids production, specifically in 6-keto PGF1α and PGE2, was observed after 2 
h. The production of these prostanoids at 10 min decreased significantly upon 
indomethacin pre-treatment.  
We examined its mechanism of action on cultured RAW264.7 macrophages by 
treating the cells with sub-cytotoxic concentration of inflamin followed by assay or 
western blot analysis. COX-1 enzymatic activity increased significantly at 10 min but 
no change in expression level was observed following inflamin administration. COX-
2 enzyme was induced after 3 h which appears to start the second wave of prostanoids 
production. AACOCF3, an inhibitor of cPLA2 enzyme, significantly reduced 6-keto 
PGF1α production induced by inflamin administration. Thus, cPLA2 plays a key role 
in the prostanoids biosynthesis. Following inflamin administration, the cPLA2 
enzymatic activity peaked at 10 min with 62% increase in its activity compared to 
control. Western blotting showed that cPLA2 was phosphorylated at Ser505 within 5 
min of inflamin administration. Thus, inflamin induces the increase in cPLA2 activity 
by phosphorylation at Ser505, which in turn increases the rate of arachidonate 
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recommendations of the IUPAC-IUBMB Joint Commission on Biochemical 
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Snakes (class Reptilia and suborder Serpentes) are spectacular creatures which 
according to biologists have evolved from lizards about 100-120 million years ago 
(Harris, 1991) and were the last group of reptiles to appear on our planet. They are 
elongate, legless, carnivorous reptiles that can be distinguished from lizards by their 
lack of eyelids and external ears. Lack of limbs does not make them handicapped but 
they have adopted various modes of locomotion, the most common of all is termed as 
‘lateral undulatory’ (Phelps, 1981). The movement of a snake is a fine muscular 
action co-ordinated through the vertebrae as the snake progresses. 
Snakes can be classified into non-venomous or venomous snakes. Constrictors, the 
non-venomous snakes, asphyxiate their prey by first ambushing and then looping 
themselves around the victim and squeezing it until it stops breathing. However, 
Venomous snakes bite their prey, injecting a toxin into the victim. Inland taipan 
(Oxyuranus microlepidotus) is the most venomous snake in the world (Sutherland, 
1994) with LD50 determined to be 0.010 mg/kg in mice (Broad et al., 1979). 
 
1.1.1 Venom gland 
Evolution of reptiles has led to the inclusion of rich suite of oral glands (Kochva, 
1978). Reptiles are equipped with many of these glands which are usually used for 
lubrication and conditioning of prey. The venom glands and the Duvernoy’s glands 
are just two of several glands which are possessed by snakes. Some groups of 
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colubrids have Duvernoy’s gland which is not found in viperid or elapid snakes 
(Kochva, 1978; Weinstein and Kardong, 1994). However, viperids and elapids 
possess a more specialized gland known as venom gland. Venom gland is described 
as a capsule of connective tissue that holds the secretory parenchyma within.  It has a 
plenty of space which acts as a large reservoir of ready venom that exits the main 
venom gland and passes through the accessory venom glands before reaching the base 
of the fang (Kardong, 2002). 
 
1.1.2 Evolution of venom gland 
Less than 30 million years ago there was a rapid change in environmental conditions, 
like radiation of prey species and development of more open habitats. To counteract 
this, Duvernoy’s gland evolved as a venom producing apparatus in snakes as a 
strategy of passive immobilization by envenomation (Savitzky, 1980). Subsequently, 
these glands were hypertrophied and evolved into more specialized venom glands. 
Venom gland is homologous to Duvernoy’s gland but they are anatomically different 
from each other (Kochva, 1965; Gans and Elliott, 1968; Kochva and Gans, 1970; 
Kochva and Wollberg, 1970). Venom gland has evolved into a high-pressure system 
in contrast to Duvernoy’s gland which is a low-pressure system to deliver venom into 
or onto prey (Kardong and Lavı´n-Murcio, 1993). Duvernoy’s gland do not have 
extensive venom reservoir but venom gland evolved into a reservoir which can hold a 
large store of ready venom that is injected under pressure in a sudden pulse. 
 
1.2 Venomous snakes 
Venomous snakes have specialized venom glands along with fangs which enable 
them to bite their prey (Klemmer, 1968). 1300 species of snakes are venomous out of 
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total 3200 species reported (Hider et al., 1991) but only 15 percent of the total number 
of snake species are considered dangerous to man (Gold et al., 2002). Venomous 
snakes are widespread all over the world. However, they are not found in several 
islands, Ireland, New Zealand, Iceland, the Azores and Canary islands. 
 
1.2.1 Classification of venomous snakes  
Previously, venomous snakes were classified into five different families: the 
Colubridae, which possess small rear fangs; the front-fanged Elapidae and 
Hydrophiidae; and the viper group consisting of the Viperidae and Crotalidae (Hider 
et al., 1991; Harris, 1991). But recently, they have been classified into seven families: 
Colubridae, Elapidae, Homalopsidae, Lamprophiidae, Pareatidae, Viperidae, and 
Xenodermatidae (Pyron et al., 2011). Elapidae can be further classified into Elapinae, 
Hydrophiinae, and Laticaudinae subfamilies.  
 
1.2.2 Marbled sea snake (Aipysurus eydouxii) 
Aipysurus eydouxii, a sea snake, also known as Marbled sea snake or spine-tailed sea 
snake belongs to the Elapidae family (subfamily Hydrophiinae) (Figure 1.1). 
Aipysurus eydouxii snake is dispersed along Australia (North Territory, Queensland, 
West Australia), South China Sea, Gulf of Thailand, Indonesia, West Malaysia, 
Vietnam and New Guinea (Kharin, 1981). It can grow up to a maximum total length 
of 115 cm. 
The venom gland and the accessory gland of sea snakes are smaller in size compared 
to other terrestrial elapid snakes (Gopalakrishnakone and Kochva, 1990). However, 
Notechis scutatus, a terrestrial Australian elapid, also possess a reduced accessory 
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gland and a narrow and elongated venom gland, as in the sea snakes. A. eydouxii has a 
short fang (1.0 mm) (Voris and Voris, 1983) and relatively small venom gland, but it 
is still functioning (Gopalakrishnakone and Kochva, 1990).  
Only 0.6 mg venom per snake is obtained after milking due to its small venom gland 
(Tu, 1974). The LD50 was determined to be 4 – 12 µg per gram body weight of mouse 
when injected i.v. (Gopalakrishnakone and Kochva, 1990). Therefore, the toxicity of 
the venom is very low. The small quantity and the low toxicity of the venom most 
likely make this snake less dangerous compared to other sea snakes (Tu, 1974). There 
have been no reports of human fatality due to A. eydouxii (Halstead, 1970).  
A. eydouxii had evolved to feed exclusively on fish eggs due to its loss of venom 
toxicity (Li et al., 2005). Geniomucosalis-like muscle, which originates on the lower 
jaw and inserts on the oral mucosa, was noticed in sea snakes that feeds on fish eggs 
(McCarthy, 1987). It is believed that the feeding mechanism of fish eggs eating sea 
snakes such as A. eydouxii is via suction because it is possibly the easiest way of 
dealing with small prey items. Contraction of the geniomucosalis-like muscle would 
depress the floor of the mouth and this, in turn, might generate a small suction force 
(McCarthy, 1987). If suction is applied, objects with similar mass as fish eggs such as 
sand grains will be ingested as well.  
Teeth are very important feature for snakes that feed on mobile prey to prevent them 
from escaping. They serve to hook onto prey while the snake’s skull bones advance 
over it for ingestion of the prey. A. eydouxii has numerous teeth but they are very 
small and poorly implanted. Nevertheless, teeth in egg-eaters are obviously not 



















Venom gland compressor of A. eydouxii is pretty large and it is divided horizontally 
into ventral and dorsal part that is coupled to venom gland. The piece of evidence that 
A. eydouxii have a large compressor and an, albeit small venom gland, indicates that 
their venom apparatus may be used as a defense weapon against potential predators 
(Gopalakrishnakone and Kochva, 1990). 
 
1.3 Snake venom 
Snake venom has been the mesmerizing subject of research for the scientists not only 
to develop antidotes to neutralize the major toxic ingredients present in the venom, 
but also to understand molecular evolution, pharmacology, and design new protein or 
peptide molecules with therapeutic potential (Dufton, 1993). Snake venoms are 
utilized in both defense and attack. So, they have components designed not only to 
immobilize prey quickly, but also to aid digestion (Hider et al., 1991; Dufton and 
Hider, 1988).  
Venom is only produced by secretory cells, one of the three major cell types present 
in the venom gland (Oron and Bdolah, 1978). Considerable quantity of venom, stored 
in the large central lumen present inside the venom gland, is channelled to tubular 
fang through a duct that passes through the accessory gland (Oron and Bdolah, 1973). 
The accessory gland functions to prohibit the wasteful flow of the secretions. Venom 
appears to be controlled by venom gland itself and is independent of neural control.  
Different tissues, organs and physiological systems are targeted by snake venom 
proteins which results in a diversity of symptoms such as loss of consciousness, 
drowsiness, intense localized pain, headache, vomiting, inflammation, bleeding, 
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shock, hemorrhage, necrosis and muscular paralysis (Campbell, 1979; Efrati, 1979; 
Reid, 1979; Russell, 1979; Torres et al., 2003).  
Variations in the population or individual, age, diet, geographical distribution and 
climate have an impact on venom composition (Sasa, 1999; Daltry et al., 1996a, 
1996b). But, closer the phylogenetic relationship of the snake, more related is the 
venom composition (Tu, 1996). 
 
1.3.1 Snake venom composition 
Snake venom is mainly composed up of proteins and polypeptides which constitute 
almost 90% of the dry weight of the venom. Lipids, nucleic acids, amines, 
carbohydrates and metal ions are the minor non protein constituents of snake venom 
(Devi, 1968; Bieber, 1979). The metal ions are associated with the proteins and serve 
as enzymatic cofactors (Friederich and Tu, 1971). 
Venom proteins can be classified into enzymatic and non-enzymatic proteins. The 
molecular weight of enzymes found in snake venom range from 13,000 to 150,000 
Da. However, the non-enzymatic proteins have a molecular weight ranging from 1000 
to 25,000 Da. Low molecular weight oligopeptides, which act as enzymatic inhibitors, 
have a molecular weight below 1500 Da. These peptides are reported to bind to the 
active sites of either bradykinin-deactivating enzymes (Ferreira and Vane, 1967) or 
the angiotensin I to II converting enzyme (Ferreira et al., 1970). 
 
1.3.1.1 Enzymatic proteins 
Snake venoms are rich in water-soluble enzymes (Zeller, 1977). Snake venoms have 
more than 20 enzymes and 12 of them are reported in all venoms, although their 
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abundance differ strikingly (Hider et al., 1991). The enzyme levels of elapid venoms 
is 25 to 70% (Mebs, 1969) of the total dry matter, whereas the corresponding range 
for crotalid and viperid venoms fall in the range 80 to 95% (Hider et al., 1991). 
Hydrophid venoms are found at the lower end of the elapid range in terms of 
enzymatic content. 
The major groups of enzyme present in snake venom are phospholipases A2 (PLA2), 
serine proteinases, metalloproteinases, phosphodiesterases, acetylcholinesterase, L-
amino acid oxidases, glycosidase, hyaluronidase and nucleotidases (Torres et al., 
2003). Many of these are hydrolases which possess a digestive role, for example 
proteinases, exo- and endopeptidases, phosphodiesterases, and phospholipases. 
Hyaluronidase is present in all snake venoms and has a “spreading action” which 
facilitates the distribution of snake venom components throughout the tissues of the 
prey (Hider et al., 1991). Apart from their enzymatic action, these enzymes exercise 
various pharmacological activities including neurotoxic, myotoxic, cardiotoxic, 
hemorrhagic, hemolytic, procoagulant and anticoagulant effects (Torres et al., 2003). 
 
1.3.1.1.1 Phospholipases A2 (PLA2) 
Phospholipases are enzymes that hydrolyze 3-sn-phosphoglycerides. They are 
classified as phospholipase A1, A2, C or D depending upon the precise site of 
hydrolysis. Phospholipase B, an additional class of phospholipases, hydrolyzes 
lysophosphatides (Harris, 1991). Snake venom are the rich sources of secretory 
phospholipases and most of the venom phospholipases belong to the PLA2 class as 
they hydrolyze the sn-2 ester bond of 3-sn-phosphoglycerides, releasing fatty acids 
and lysophospholipids (Kini, 1997). 
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Generally, snake venom PLA2 enzyme is a single chain polypeptide of around 118 to 
130 amino acid residues cross-linked by seven disulfide bonds (Scott 1997). Since 
these enzymes are homologs of mammalian pancreatic phospholipases, it was logical 
to assume that the venom PLA2 would be synthesized and stored as inactive 
proenzymes. But, it was surprising to find that the venom PLA2 enzymes do not 
possess a prosequence at all (Ducancel et al., 1988a, 1988b). 
Snake venom PLA2 enzyme can be classified into class I and II (Figure 1.2). Based on 
the absence or presence of pancreatic loop, class I can be further divided into class IA 
and IB, respectively. Class I enzymes exhibit an insertion of two to three amino acid 
residues (‘elapid’ loop) in between 52 to 65 residue of PLA2 enzyme, which can be 
further extended by five amino acid residues as in the case of mammalian pancreatic 
PLA2 enzyme (‘pancreatic’ loop). However, Class II enzymes do not possess elapid or 
pancreatic loop. In fact, the disulfide bridging is also different between class I and II. 
Class I has the Cys11-Cys77 disulfide bridge, but class II possess an alternative 
Cys51-Cys133 disulfide linkage (Dufton and Hider,1983). A sub-group of the class II 
PLA2 enzyme possess a Lys - for - Asp substitution at position 49 which is an 
important Ca2+ binding hydrolytic site.  
Although most of the venom PLA2 probably have a digestive role and have little or no 
toxicity, the toxic PLA2 enzymes are among the most toxic of all venom toxins 
(Harris, 1998). They are variously involved in presynaptic and postsynaptic 
neurotoxicity (Strong et al., 1976), myotoxicity (Gopalakrishnakone et al., 1984; 
Ponraj and Gopalakrishnakone, 1995), cardiotoxicity (Lee et al., 1977), hemolytic 
(Condrea et al., 1981), anticoagulant effect (Verheij et al., 1980), antiplatelet (Chen 










Figure 1.2 Three-dimensional structures of class I (A) and class II (B) snake venom 
PLA2. The elapid loop region in class I PLA2 is indicated by arrow. Figure is 





and Chen, 1989), hypotension (Huang, 1984), internal hemorrhage (Vishwanath et al., 
1987), organ or tissue damage and edema (Vishwanath et al., 1987, 1988).  
 
1.3.1.1.2 Acetylcholinesterases 
Acetylcholinesterases are enzymes that hydrolyze the neurotransmitter acetylcholine, 
producing choline and an acetate group. It is better known in the context of 
cholinergic neurotransmission than as a snake venom component. 
Acetylcholinesterase quickly hydrolyzes the quanta of acetylcholine released from the 
presynaptic membrane which ensures that nAchR is stimulated briefly and repeatably. 
Acetylcholinesterase was believed to be a component of Elapid and Hydrophid snake 
venoms (Zeller, 1948; Iwanaga and Suzuki, 1979) but later it was reported that 
mambas and sea snakes either do not contain or have traces of the enzyme (Tan et al., 
1991; Tan and Ponnudrai, 1991). More importantly, now the enzyme has been 
identified in some viperid snakes like Trimeresurus purpureomaculatus (shore pit 
viper) (Tan and Tan, 1988b) and Echis carinatus (carpet viper) (Bhattacharya and 
Gaitonde, 1979). But there is no reasonable explanation as to why the enzyme should 
be present in certain venoms. 
 
1.3.1.1.3 L-Amino acid oxidases 
L-Amino acid oxidases are the flavoproteins that catalyze the oxidative deamination 
of L-amino acids to form α-ketoacid along with ammonia and hydrogen peroxide. The 
enzyme occurs extensively in nature (Bright and Porter, 1975; Tan and Ponnudurai, 
1992) and snake venoms are the richest source of it. L-Amino acid oxidase enzymatic 
activity can be found in venoms from most genera (Tan and Ponnudurai, 1992) and is 
13 
 
solely responsible for the yellow colour in snake venoms. L-Amino acid oxidases are 
widely distributed in the family of Viperidae, Crotalidae and Elapidae (Du and 
Clemetson, 2002; Pawelek et al., 2000). 
L-Amino acid oxidase has a molecular weight ranging from 85,000 – 140,000 Da. 
The enzyme is a glycoprotein containing 3-4% carbohydrate and is usually composed 
up of two subunits. The enzyme is a flavoprotein with two molecules of FMN or FAD 
per mole of the enzyme. The flavin exhibits absorption maxima at 275, 390, and 462 
nm and is accountable for the yellowish colour of the enzyme (Wellner, 1971). 
The 3D structure of L-Amino acid oxidase from Calloselasma rhodostoma was 
solved by X-ray crystallography (Pawelek et al., 2000). The enzyme is a dimer as 
reported before and each subunit consists of three domains, namely substrate binding 
domain, helical domain and FAD-binding domain. The crystal structure revealed that 
the enzyme has two glycosylation sites at positions Asn172 and Asn361 which seems 
to be important for the catalytic activity (Torii et al., 2000).  
It is surprising to note that specific activity of the enzyme from different venom 
sources varies a lot. When L-Leu was taken as a substrate, the specific activity of the 
enzyme from C. rhodostoma, N. kaouthia, and O. hannah was 0.54, 4.59, and 20.9 
µmol/min/mg respectively. The enzyme is stabilized by certain amino acids but at 
higher concentration they inhibit the enzyme (Meister and Wellner, 1963). 
L-Amino acid oxidase from various snake venoms were reported to be moderately 
lethal with i.v. LD50 of around 5-9 µg/g in mouse which was less fatal than the 
corresponding venoms (Russell et al., 1963; Tan and Saifuddin, 1989). The enzyme 
has been reported to induce edema, inhibit platelet aggregation and exhibit potent 
antibacterial activity (Tan and Choy, 1993; Nathan et al., 1982; Stiles et al., 1991). 
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1.3.1.2 Non-enzymatic proteins 
In addition to enzymes, snake venom contains non-enzymatic proteins which 
potentiate the assault caused by enzymes upon the prey. All of these non-enzymatic 
proteins are rich in disulfide bonds which makes them more robust and relatively 
stable molecule. They include three-finger toxins, serine proteinase inhibitors, 
disintegrins, C-type lectin-related proteins, helveprins/ CRISPs, waprins, sarafatoxins, 
nerve growth factors, natriuretic peptides and bradykinin-potentiating peptides (Kini, 
2002; Mochca-Morales et al., 1990; Torres et al., 2003; Yamazaki et al., 2003).    
 
1.3.1.2.1 Three-finger toxins 
Three-finger toxins (3FTX) are well characterized non-enzymatic proteins isolated 
from the snake venom of elapids (cobras, kraits and mambas) and hydrophids (sea 
snakes and sea kraits) (Fry et al., 2003a). Recently, it has been known that 3FTXs are 
also found in the venom of colubrids and crotalids (Pawlak et al., 2006; Fry et al., 
2003b; Lumsden et al., 2005; Pahari et al., 2007). 3FTXs are rich in disulfide bonds 
and may have four or five disulfide bridges, of which four are conserved in all 
members (Endo and Tamiya, 1991). These proteins have a similar fold consisting of 
three finger-like loops made of β-sheet structure extending from a small, hydrophobic, 
globular core that is cross-linked by four disulfide bridges (Menez, 1998; Tsetlin, 
1999). 
The structurally conserved regions of all the 3FTXs contribute towards the proper 
folding, structural integrity and stability of the polypeptide chain. Apart from eight 
conserved cysteine residues found in the toxin, Tyr25 or a homologous aromatic 
residue Phe27 is also conserved in most toxins and is necessary for the stability of the 
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antiparallel β-sheet structure (Torres et al., 2001) and proper folding (Dufton and 
Hider, 1983; Antil et al., 1999). Some conserved charged residues (example, Arg39 in 
erabutoxin-a) stabilize the native conformation of the toxin by forming a salt bridge 
with the C- or N-terminus of the toxin (Endo and Tamiya, 1991). 
3FTXs are broadly classified as short-chain (60-64 residues) and long-chain (66-75 
residues) toxins with four and five disulfide bridges respectively (Tsetlin, 1999). 
However, some proteins like pseudonajatoxin b (82 residues) and denmotoxin (77 
residues) purified from the venoms of Pseudonaja textilis (Gong et al., 2001) and 
Boiga dendrophila (Pawlak et al., 2006) respectively have few extra amino acid 
residues. Despite having almost similar structure, they exhibit completely diverse 
functions with the active site distributed variably on all the three loops of the toxins. 
3FTXs have diverse molecular targets in the prey. For example, short-chain and long-
chain α-neurotoxins target muscle nicotinic acetylcholine receptors (nAChRs) 
(Changeux, 1990; Tsetlin, 1999), long-chain α-neurotoxins target neuronal α7 nAChR 
(Tsetlin, 1999), κ-bungarotoxins target α3 and α4 nAChRs (Tsetlin, 1999), fasiculins 
target acetylcholinesterase (Eastman et al., 1995), Calciseptine and related toxins 
block the L-type Ca2+ channels (de Weille et al., 1991; Albrand et al., 1995), 
cardiotoxins/cytotoxins target the cell membranes (Bilwes et al., 1994), dendroaspin 
target integrin αIIbβ3 (McDowell et al., 1992), and cardiotoxin A5 target integrin αvβ3 
(Wu et al., 2006). This observation suggests that these toxins act like ‘sibling toxins’ 
sharing the same fold while performing ‘multiple missions’ (Kini, 2002) (Figure 1.3).  
 
1.3.1.2.2 Sarafotoxins  
Sarafotoxin (SRTX) is a unique venom product of burrowing asps belonging to the 
snake genus Atractaspis. The first fractionation of A. engaddensis venom revealed 
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highly toxic proteins in the low molecular weight peak (Kochva et al., 1982).  Further 
purification of the highly toxic fractions resulted in the isolation and characterization 
of the first three sarafotoxins: SRTX-a, -b, and –c (Wollberg et al., 1988; Takasaki et 
al., 1988).  
Endothelin isoforms emerge from distinct precursors but SRTX isopeptides are 
simultaneously encoded by a polycistronic precursor. The organization of SRTXs 
cDNA results in minimal use of transcriptional and translational machinery to 
produce multiple copies of SRTXs which probably explains why SRTXs are 
abundantly found in A. engaddensis venom in contrast to pico-molar amount of ETs 
in mammalian tissues (Joseph et al., 2004).  
The sarafotoxins are twenty one amino acid residue polypeptides with two conserved 
disulfide bridges, between Cys1-Cys15 and Cys3-Cys11. SRTXs constitute a family 
of isopeptides that are structurally and functionally similar to mammalian endothelins 
(ETs). Both the group of peptides have the same cysteine skeleton and all of them 
have a hydrophobic carboxy-terminal tail. The most significant differences between 
the various peptides of the SRTX/endothelin family exist within the sequences of the 
inner loop Cys3-Cys11. SRTX-b has an extended structure at N-terminal, followed by 
a turn and a cysteine-stabilized α-helical motif, and finally a random coil at C-
terminal (Atkins et al., 1995) (Figure 1.4).   
Like Endothelins, SRTXs are potent vasoconstrictors (Kochva et al., 1993). 
Cumulative application of SRTX-b induced dose dependent increase in contraction on 
different smooth muscle preparations and maximal effects were obtained at around 
10-7 M of the toxin (Wollberg et al., 1989, 1991, 1992). The vasoconstriction effect of 
SRTX-a, -b, and ET-1 were similar. However, SRTX-d/e showed very low 
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contraction efficacy and potency in the rabbit aorta system (Bdolah et al., 1989b). On 
the other hand, SRTX-c, which is not a potent vasoconstrictor, caused prolonged 
relaxation at high concentrations (Wollberg et al., 1989).   
 
1.3.1.2.3 Cysteine-rich secretory proteins (CRISPs) 
Cysteine-rich secretory proteins (CRISPs) have been purified from numerous animal 
tissues, including reptile venoms (Hill and Mackessy, 2000; Yamazaki and Morita, 
2004; Sanz et al., 2006). They are single chain proteins with molecular weight 
ranging from 20-30 kDa and possess 16 strictly conserved cysteines, which are 
involved in the formation of 8 disulfide bonds. Most importantly, 10 of 16 cysteines 
are clustered at C-terminal of the protein (Yamazaki et al., 2003). 
Venom CRISPs have shown a wide variety of biological activities, including blockage 
of calcium and potassium currents in neurons (Nobile et al., 1996, 1994), blockage of 
BKCa channels (Wang et al., 2005), blockage of Ca2+ release from sarcoplasmic 
reticulum (Morrissette et al., 1995), inhibition of vascular smooth muscle contraction 
(Yamazaki et al., 2002), induction of hypothermia in prey animals (Mochca-Morales 
et al., 1990). Despite the varied functions displayed by CRISPs, many of them do not  
have any identifiable functions (Chang et al., 1997; Yamazaki et al., 2002; Jin et al., 
2003). 
Following the recent crystallization studies on three different CRISPs, the structural 
chemistry of venom CRISPs is well understood (Guo et al., 2005; Shikamoto et al., 
2005; Wang et al., 2005). They have highly conserved primary, secondary and even 
tertiary structure. Due to this reason, new members of this family are identifiable on 





Figure 1.3 Structural similarities among ‘sibling’ three-finger toxins. (A) Erabutoxin-
a (1QKD), (B) α-Bungarotoxin (2ABX), (C) Cardiotoxin V4 (1CDT), (D) κ-
Bungarotoxin (1KBA), dimer (inset), (E) Candoxin (1JGK), (F) Fasciculin-2 (1FAS), 
(G) Muscarinic toxin MT-2 (1FF4), (H) FS2 toxin (1TFS), and (I) Dendroaspin 
(1DRS). It is important to notice that all these sibling toxins share similar structural 
fold, but they differ in their biological activities. Figure is reprinted with the 
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characterized structurally from the venom of Trimeresurus stejnegeri (Guo et al., 
2005). The crystal structure of stecrisp showed two distinct regions connected by a 
folded hinge or bridge (Figure 1.5). The first of these regions, from N-terminus of the 
protein, was named as PR-1 domain as it was homologous to the plant pathogenesis 
group 1 protein family. The C-terminal region, the second region of the protein, was 
called the cysteine-rich domain (CRD). Three disulfide bonds were found in PR-1 
domain, two in the hinge region, and remaining three disulfide bonds were found in 
cysteine-rich domain. 
The precise functional sites of venom CRISPs have not been determined for any of 
the available molecule. The wide variety of biological effects suggests that there may 
be multiple functional sites or residues. The CRISP toxins pseudechetoxin and 
pseudecin were found to block cyclic nucleotide-gated ion (CNG) channels with 
different affinity. On the basis of different affinity of these two molecules towards the 
same channel, the researchers proposed that a string of basic residues (Lys167, 
Lys174, Arg175), which were found in pseudechetoxin but were lacking in pseudecin, 
may interact with CNG channels electrostatically.    
 
1.3.1.2.4 Snake venom nerve growth factors 
Nerve growth factor (NGF) belongs to neutrotrophin family of proteins that plays an 
important role in the survival and maintenance of neurons. Its activity was first 
described in sarcomas (Cohen et al., 1954) and later in two distinct species of snakes, 
Agkistrodon piscivorus (eastern cottonmouth) and Crotalus adamanteus (eastern 
diamondback rattlesnake). Snake venom NGF was first purified from Naja naja, a 
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of the NGF from N. naja were quite similar to that of the mouse protein. 
Subsequently, NGF was purified and characterized from the venom of other snakes, 
such as Bothrops atrox (Glass and Banthrope, 1975), Crotalus adamentus (Perez-Polo 
et al., 1978), and Naja sputatrix (Koh et al., 2004).  
The NGFs of many Naja species are homodimers, possess a molecular mass of 
approximately 25 kDa, and do not have any glycosylation. In contrast, B. atrox, 
Agkistrodon rhodostoma, and Vipera ammodytes NGFs possess a molecular size of 
35 kDa. This difference in molecular weight can be accounted by the presence of 
carbohydrate moiety (Kostiza and Meier, 1996). It has been hypothesized that Asn23 
is the glycosylation site in snake venom NGFs. However, the functional importance of 
glycosylation is completely unknown. It seems that presence of carbohydrate moiety 
is not required for the activity as both glycosylated and non-glycosylated NGFs 
display an almost similar ability to induce neuronal outgrowth (Katzir et al., 2003). 
But, it has been predicted that glycosylation of NGFs may increase their stability in 
the venom gland or after envenomation.   
The physiological role of snake venom NGF is still unknown. It is believed to have 
some physiological effects on non-neuronal cells or tissues. According to a 
hypothesis, prior contact of NGF to basophil cells may enhance the degranulation 
process upon CVF or PLA2 treatment (Kostiza and Meier, 1996). It is also suggested 
that NGF can act as a carrier of chaperone protein to deliver various toxins, like 
phospholipases, to the target cells that lack receptors for these toxins (Levi-







Waprins are a new family of snake venom proteins which show structural similarity to 
WAPs (whey acidic proteins) (Torres et al., 2003). The WAP domain consists of 
around 50 amino acid residues including 8 conserved cysteine residues involved in the 
formation of 4 disulfide bonds. Although the cysteine residues are conserved, the 
inter-cysteine segments are completely different among the members of WAP family, 
which implies that the molecular surfaces of these proteins are also different. Thus, it 
is possible that these proteins might interact differently with the molecular targets and 
have different physiological effects. Nawaprin, the first member of this family, was 
isolated from Naja nigricollis (Torres et al., 2003). It has a molecular mass of 5288 
Da and consisted of 51 amino acid residues. Nawaprin has a relatively flat and disc-
like structure as determined by NMR spectroscopy (Figure 1.6). It has a spiral 
backbone configuration that forms inner and outer circular segments, which are held 
together by four disulfide bridges. But, its function is still unknown. Another member 
of the same family, omwaprin, was isolated from Oxyuranus microlepidotus (Nair et 
al., 2007). It shows selective antibacterial activity against Gram-positive bacteria.  
 
1.4 Inflammation 
Inflammation is a localized protective reaction of tissues to get rid of the cause and 
effect of injury such as microbes, toxins or necrotic tissues. This leads to an increase 
in blood supply, increase in capillary permeability and leukocytes migration towards 
the site of injury which ultimately leads to redness, swelling, heat and pain. Following 
tissue injury, several inflammatory mediators such as chemokines, cytokines, 









Figure 1.6 Structure o
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endothelial cells and resident cells, chiefly mast cells, tissue macrophages and 
dendritic cells. These mediators orchestrate the inflammatory events whenever a toxin 
or infection is encountered.    
Inflammatory response should be tightly co-ordinated, too little and the body is 
overwhelmed but too much can result in severe disease symptoms. Chronic 
inflammation is a serious threat and it may lead to various diseases such as diabetes, 
atherosclerosis, alzheimer’s disease, parkinson’s disease, psoriasis, rheumatoid 
arthritis and cancer (Dandona et al., 2004; Laberge et al., 2005; McGeer and McGeer, 
2001, 2004; Bos et al., 2005; Goronzy and Weyand, 2005; Moss and Blaser, 2005).   
 
1.4.1 Macrophages 
Macrophages are white blood cells originating from bone marrow. They circulate in 
the blood stream as monocytes and migrate into the surrounding tissue where they 
mature into macrophages (Johnston, 1988). Macrophages alongwith neutrophils are 
the first ones to reach the site of injury. Unlike short-lived neutrophils, macrophages 
are long-lived cells which can survive up to a maximum of several months. 
Macrophages are present as Kupffer cells (liver), Langerhans cells (skin), osteoclasts 
(bone), microglia (brain), alveolar macrophages (lung) and as pleural or peritoneal 
macrophages in body cavities. Activated macrophages have ruffled plasma 
membrane, an increased capacity for adhesion and spreading as well as formation of 
pseudopods. Some of the key functions of macrophages in the immune system are 
production of cytokines, complement components and eicosanoids, phagocytosis, NO 




1.4.2 Phospholipases  
Lipids can not only form cell membrane but they are also involved in cellular 
signalling. Cell membrane is mainly composed of phospholipids, which has a glycerol 
backbone coupled with two fatty acid chains and a phosphate group coupled to an 
alcohol, such as ethanolamine, choline, serine or inositol. Phospholipases are enzymes 
that hydrolyze phospholipids and they are classified on the basis of the position of 
cleavage on the glycerol backbone. Four major phospholipases are- 
• Phospholipase A: phospholipase A1 (PLA1) and phospholipase A2 (PLA2) 
hydrolyze ester bonds at sn-1 and sn-2 position respectively 
• Phospholipase B: hydrolyzes at both sn-1 and sn-2 position  
• Phospholipase C: hydrolyzes before the phosphate group resulting in the 
release of a phosphate-containing head group and diacylglycerol 
• Phospholipase D: cleaves after the phosphate group resulting in the release of 
phosphatidic acid and an alcohol 
 
1.4.3 Cytosolic phospholipases A2 (cPLA2) 
PLA2, which catalyzes a rate limiting step in eicosanoids formation, is responsible for 
the production of arachidonic acid from membrane phospholipids. Arachidonic acid is 
usually found at sn-2 position of phospholipids. Three different groups of PLA2s are 
secreted calcium-dependent PLA2 (sPLA2), cytosolic calcium-dependent PLA2 
(Group IV cPLA2), cytosolic calcium-independent PLA2 (Group VI iPLA2) (Dennis, 
1997). Group IV cPLA2 includes cPLA2α (GIVA), β (GIVB), γ (GIVC), δ (GIVD), ε 
(GIVE) and ζ (GIVF) (Ghosh et al., 2006). These enzymes possess a conserved 
Ser/Asp active site dyad and an Arg residue, which are crucial for catalytic activity. 
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Amongst all, cPLA2α is extensively studied due to its specificity for arachidonic acid 
at sn-2 position and essential role in agonist-induced eicosanoids release (Clark et al., 
1995). It contains two catalytic domains A and B interspaced with isoform-specific 
sequences. The enzyme has a N-terminal C2 domain, which is involved in calcium-
dependent phospholipid binding (Clark et al., 1991; Nalefski et al., 1994).  
Enzymatic activity of cPLA2 is regulated by intracellular calcium concentration and 
phosphorylation (Channon and Leslie, 1990; Clark et al., 1991, 1995; Lin et al., 1993; 
Qiu et al., 1993; Leslie, 1997). Translocation of cPLA2α from cytosolic region to 
membrane is an important step of enzyme regulation, which normally happens by an 
increase in intracellular calcium concentration that binds to C2 domain (Evans et al., 
2001). cPLA2α has been shown to translocate mainly to nuclear envelope or 
endoplasmic reticulum, where cyclooxygenase and 5-lipoxygenase also localize 
(Glover et al., 1995; Schievella et al., 1995; Sierra-Honigmann et al., 1996; 
Hirabayashi et al., 1999). However, the binding of cPLA2α to the membrane can be 
stabilized by catalytic domain in a calcium-independent manner (Evans and Leslie, 
2004). Reports suggest that cPLA2 enzyme is activated without detectable change in 
the calcium concentration (Wijkander and Sundler, 1992; Balsinde et al., 2000). 
In most of the cases, cPLA2α is regulated by phosphorylation in addition to increase 
in intracellular calcium concentration. The enzyme can be phosphorylated at several 
sites in the catalytic domain such as S505, S515 and S727 following which the 
enzymatic activity increases significantly (Ghosh et al., 2006). Depending on the 
stimulus and cell type, cPLA2α can be phosphorylated by MAP kinases at S505 (Lin 
et al., 1993; Borsch-Haubold et al., 1999), by Ca2+ / calmodulin dependent protein 
kinase II (CamKII) at S515 (Muthalif et al., 2001) or by MAP kinase interacting 
kinase (Mnk-1) or a closely related isoform at S727 (Hefner et al., 2000). Since Mnk-
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1 is activated by members of the MAP kinase family (Waskiewicz et al., 1997) and 
ERK can be activated downstream of calmodulin-dependent protein kinase II 
(CaMKII) (Illario et al., 2003), it is possible that the phosphorylation of the sites is 
interactive. How phosphorylation of cPLA2α at various sites increases its activity is 
not fully clear, but it influences the membrane binding. A recent study reveals that 
phosphorylation at S505 increases the affinity of cPLA2α enzyme towards 
phospholipids at low Ca2+ concentration (Das et al., 2003). Phosphorylation at S505 
and S727 have a crucial role in regulating arachidonate release under transient 
increase in Ca2+ concentration, but has less effect under sustained increase in Ca2+ 
concentration (Hefner et al., 2000).  
 
1.4.4 Eicosanoids 
Eicosanoids can virtually mediate every step of inflammation. These are oxygenated 
20-carbon fatty acids derived from arachidonate. The arachidonic acid cascade is a 
chain of intricate biosynthetic pathways that leads to a number of lipid mediators from 
arachidonate, including prostaglandins, thromboxanes, leukotrienes, lipoxins, 
hepoxilines, isoprostanes and various hydroxyl, epoxy and hydroperoxy fatty acids. 
They have an effect on almost every cell reflecting the central role of these lipid 
mediators in maintenance of physiological homeostatis. Although eicosanoids were 
originally recognized for regulating vascular dilatation, vascular permeability and 
platelet aggregation, they have been shown to play key roles in the immune response, 
in inflammatory, autoimmune and allergic diseases, in chronic tissue remodeling and 
in cancer. Most of the eicosanoids have pro-inflammatory properties but some are 
found to have anti-inflammatory properties. Lipoxins are anti-inflammatory mediators 
and PGE2 exhibit both anti- and pro-inflammatory effects. Owing to their biological 
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importance, the production of eicosanoids is highly regulated, particularly via 
expression of specific cellular enzymes. They interact with receptors on the cell 
surface or nuclear membrane in an autocrine or paracrine manner to exert their 
effects. They have a short half-life from seconds to minutes and can be degraded both 
enzymatically or non-enzymatically (Shimizu, 2009). 
 
1.4.5 Prostanoids biosynthesis: the COX pathway 
Prostanoids (prostaglandins, prostacyclin and thromboxane) biosynthesis (Figure 1.7) 
is initiated by cyclooxygenase (COX) enzymes, existing in two isoforms COX-1 and 
COX-2. COX-1 is widely distributed and expressed constitutively whereas COX-2 is 
an inducible enzyme found prominently at the sites of inflammation but is also 
constitutively expressed in some tissues, such as brain and kidney. COX-1 is an 
enzyme which is involved in mediating homeostatic functions such as renal water and 
electrolyte balance, platelet aggregation and gastric cytoprotection. However, COX-1 
has been reported to contribute significantly in the generation of prostanoids that can 
induce inflammation (Wallace et al., 1998). COX-2 is shown to be an important 
source of prostanoids in pathological conditions such as inflammation and cancer. The 
COX enzymes convert arachidonic acid into unstable intermediates PGG2 and PGH2, 
which are subsequently converted to active end products PGE2, PGI2, PGF2α, TXA2, 
and PGD2 by specific terminal synthases. Although macrophages synthesize a broad 
range of prostanoids, most other cell types are characterized by a single predominant 
prostanoid. Therefore, mast cells chiefly secrete PGD2, platelets TXA2, endothelial 
cells PGI2 and epithelial cells, fibroblasts and smooth muscle cells primarily secrete 
PGE2 (Brock and Peters-Golden, 2007). Single enzyme isoforms for PGI2, PGF2α and 







Figure 1.7 Prostanoids biosynthetic pathway. Phospholipase A2 or DAG lipase 
converts phospholipids into arachidonic acid which is later converted into PGH2 by 








































PGD synthases are present in brain and mast cells/macrophages, respectively. At least 
three isoforms of PGE synthases are found, all of which require reduced glutathione 
as a cofactor.  
Prostanoids are secreted out of the cell through a prostanoid transporter or other 
carriers, activating G-protein-coupled receptors that lead to a variety of biological 
functions in almost all tissues (Narumiya and FitzGerald, 2001). Both PGE2 and PGI2, 
the predominant pro-inflammatory prostanoids, induce leukocyte infiltration and 
edema by increasing vascular permeability and blood flow. TXA2 induces platelet 
aggregation and vasoconstriction, whereas PGI2 inhibits platelet aggregation and 
causes vasodilation. PGD2 regulates the reduction in body temperature during sleep 
and causes a contraction of bronchial airways. 
Prostanoid levels in tissues depend on their rate of synthesis as well as degradation. 
Active prostanoids are rapidly metabolized to an inactive product, which happens via 
transporter-mediated uptake into endothelial cells followed by 15-hydroxy PG 
dehydrogenase metabolism. Also the prostanoids are not stored but they are 
synthesized and secreted immediately. Therefore, under normal physiological 
conditions, only small amounts of the active compounds are detectable in the 
circulation. 
 
1.5 Focus of this study 
In the past, snake venom proteins have been used as an excellent tool for basic 
research. Some proteins found in the venom have been developed for therapeutic and 
medical diagnostic applications. But, only few snake venom components have been 
completely characterized. This provides us an opportunity to either characterize a 
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novel protein of the known family or a novel family of proteins as snake venom is a 
natural treasure-box. Thus, these proteins have the potential to benefit the 
pharmaceutical industry in the forthcoming years. 
Venom of A. eydouxii snake has not been extensively studied probably due to low 
venom yield (Tu, 1974). However, partial cDNA library of A. eydouxii venom gland 
was constructed by our lab (Li et al., 2005), which revealed the presence of few novel 
proteins; one of them encoded by 1% of the 196 clones showed no sequence similarity 
when searched against the protein database. The deduced protein contains 113 amino 
acid residues (Figure A.1). Signal peptide is coded by 19 amino acid residues at the 
N-terminal of the secretory protein (Emanuelsson et al., 2000; Petersen et al., 2011) 
and the mature protein, named as inflamin, is composed up of remaining 94 amino 
acid residues including six cysteines.   
This study was aimed to understand and characterize inflamin, which is the first 
member of a novel family of snake venom proteins. Thus, molecular biology, protein 
chemistry, pharmacological and structural biology approaches were employed to 
functionally and structurally characterize the protein. The scope of this study covered 
the following features:  
9 Recombinant expression of inflamin in bacterial system 
9 Refolding and purification of recombinant protein 
9 Structural characterization of inflamin  
9 Functional characterization of inflamin using in vivo and in vitro 
pharmacological assays 




Thus, this thesis mainly focuses on understanding the functional role of inflamin 
protein and its mechanism of action. This study will lay the foundation for further 







































Expression and purification of inflamin 
2.1 Introduction 
In past several decades, most abundant or most toxic proteins were isolated and 
characterized from snake venoms. With the advent of sophisticated techniques and 
state-of-the-art instrumentation, toxins found in smaller quantities can also be 
identified. This has led to the characterization of novel toxins of known family or a 
novel family of toxins in the recent past. For example, we have identified new 
families of snake venom proteins such as waprins (Torres et al., 2003; Nair et al., 
2007), vespryns (Pung et al., 2005), and veficolins (Ompraba et al., 2010) as well as 
several unique members of three-finger toxin family (Nirthanan et al., 2002; Pawlak 
et al., 2006, 2009; Rajagopalan et al., 2007).  Similarly, inflamin is a novel family of 
toxin from A. eydouxii snake, which is described in this thesis.  
Recombinant expression is a great tool by which we can characterize low-abundance 
proteins. So, we have used E. coli for heterologous expression of inflamin due to its 
high growth rate and capability to express proteins in high amount. Inflamin was 
expressed both in soluble as well as insoluble fraction. But, the yield of the protein 
was much higher from insoluble fraction than the soluble fraction so we refolded the 
protein from insoluble fraction using redox buffer. Glutathione oxidized and reduced 
has been commonly used as a scaffold for the shuffling of disulfide bonds for the 
formation of thermodynamically most stable protein conformer. Protein extraction 
from the insoluble pellet has an advantage that the amount of desirable recombinant 
protein is high and the numbers of contaminating proteins are less, which makes the 
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purification of the protein relatively easy. Also the expressed protein is protected from 
the proteolytic attack.  
We illustrate a two step chromatographic approach for the purification of 
recombinantly expressed inflamin. The procedure involved affinity chromatography 
as the initial step and reverse phase-high performance liquid chromatography (RP-
HPLC) as the second step. Ni-NTA column chromatography was used to purify the 
polyhistidine-tagged inflamin as polyhistidine tag can form co-ordinate bonds with 
cobalt or nickel ions. We have used RP-HPLC as a second step of purification where 
the proteins are purified on the basis of their hydrophobicity. But, the usage of organic 
solvents in RP-HPLC can cause protein denaturation with loss of the activity. 
Fortunately, the snake venom toxins are resistant to denaturation due to robustness 
and stability provided by the disulfide linkage within the molecule. After RP-HPLC, 
the protein fractions can be lyophilized as organic solvents are highly volatile. This 
allows us to use the lyophilized powder for refolding followed by RP-HPLC 
purification to separate the conformers on a shallow gradient. The molecular weight 
and homogeneity of the protein sample was determined by electrospray ionization-









2.2 Materials and Methods 
2.2.1 Materials 
The DNA fragment encoding for inflamin was synthesized by GenScript Corporation 
(Piscataway, NJ, USA) with codon optimization for overexpression in E. coli (Figure 
1). Advantage 2 Taq polymerase was purchased from Clontech (Mountain View, CA, 
USA) and dNTP mix and DNA ladders were purchased from Invitrogen (Grand 
Island, NY, USA). Restriction endonucleases, T4 DNA ligase and E. coli SHuffle 
competent cells were obtained from New England Biolabs (Beverly, MA, USA). 
Synthetic gene was cloned in pET-M (a modified pET-32a vector, devoid of 
thioredoxin tag (trx-tag) and S-tag) (Figure A.2). Custom oligonucleotides were from 
1st Base Pte. Ltd. (Singapore). Luria-Bertani broth and agar were purchased from 
Q.BIOgene (Irvine, CA, USA) and Precision Plus Protein™ Dual-Colour Standards 
(marker for SDS-PAGE) were purchased from Bio-Rad (Hercules, CA, USA). 
Acetonitrile and trifluoroacetic acid solvents were purchased from Merck KGaA 
(Darmstadt, Germany). RP-Jupiter C18 (5 µ, 300 Å, 4.6 mm X 250 mm) column was 
purchased from Phenomenex (Torrance, CA, USA). Nickel-NTA agarose and 
QIAquick Gel Extraction Kit was purchased from Qiagen GmbH (Hilden, Germany). 
Empty columns for gravity flow were obtained from Bio-Rad (Hercules, CA, USA). 
Water was purified with a Millipore MilliQ system (Billerica, MA, USA). All other 
chemicals and reagents used were of analytical grade.  
 
2.2.2 Cloning of the synthetic gene 
The 285 bp synthetic gene was received in pUC-57 vector. The optimized gene 
sequence and the cloning strategy are illustrated in Figure 2.1 and 2.2 respectively. 
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The synthesized DNA was amplified by PCR using forward primer (5’- 
AAATGGATCCTCAGAAAAAGGCCGC-3’) and reverse primer (5’- 
AAATCTCGAGTTACAGCGGAATATGCATG-3’) having BamHI and XhoI 
restriction sites respectively. Four extra nucleotides were added at 5’ end of each 
primer to facilitate subsequent digestion by restriction endonucleases. The PCR 
mixture contained 1 μl of 1:10 diluted recombinant pUC-57 vector, 1 unit of 
Advantage 2 Taq polymerase, 1 μl of 10 mM of each primer, 1 μl of 10 mM dNTPs, 5 
μl of 10X PCR buffer in a total volume of 50 μl. The PCR conditions were as follows: 
one cycle of 94ºC for 5 min, 35 cycles of 94ºC for 30 s, 60ºC for 30 s and 72ºC for 45 
s, and a final extension at 72ºC for 10 min. 
After PCR, the amplified product was run on 1% (w/v) agarose gel followed by gel 
extraction. Both, the amplified PCR product as well as pET-M was doubly digested 
with BamHI and XhoI. Normally, the double digestion mixture consisted of ~500 ng 
of vector or insert, 1 μl each enzyme, 2 μl 10X buffer and total volume was raised to 
20 μl each with autoclaved water followed by incubation at 37°C for 2 h. The digested 
products were run on 1% (w/v) agarose gel followed by gel extraction. The ligation 
mixture contained 3:1 molar ratio of insert to vector, 1 μl of T4 DNA ligase, 2 μl of 
5X ligation buffer and total volume was raised to 10 μl with autoclaved water. The 
ligation reaction was incubated at 4°C overnight.  
 
2.2.3 Preparation of competent cells 
Before transformation, E. coli DH5α and E. coli SHuffle competent cells were 
prepared as described. Frozen stock of E. coli DH5α and E. coli SHuffle cells were 
thawed, streaked on LB agar plate without ampicillin and cultured overnight at 37°C. 








TCA GAA AAA GGC CGC CGC TAT GGC GAA GAA AAA GAA AGT CTG CTG CGC CGC TCG AAA 
TCA GAA AAA GGT AGA AGG TAT GGC GAA GAA AAA GAG AGT TTG CTA AGA AGG TCG AAA 
 S   E   K   G   R   R   Y   G   E   E   K   E   S   L   L   R   R   S   K 
 
CGC AGC AAA CTG TGG CAC CCG TCC TGT ACC TGT CCA GAT CTG AAT GAA TTC CAG CAC     
CGA AGC AAG CTG TGG CAT CCA TCC TGC ACT TGT CCA GAT TTA AAT GAA TTC CAA CAC 
 R   S   K   L   W   H   P   S   C   T   C   P   D   L   N   E   F   Q   H 
 
CGT AAA AAA CAC AAC CAT GCC TGC CCG TGT AAT GGC CTG AGT CTG CAT AGT CTG TCA   
CGT AAA AGA CAC AAC CAT GCC TGC CCC TGT AAT GGA CTC AGT TTG CAT AGT TTG TCA 
 R   K   K   H   N   H   A   C   P   C   N   G   L   S   L   H   S   L   S 
 
GAA CAT CGC AAT CAT CAT CCG CAT CGC ATC AGT AAA AAA CAT GTA CTG CAC AAA AAA 
GAA CAT CGC AAT CAT CAT CCT CAT CGC ATC AGC AAG AAA CAT GTA CTC CAT AAG AAA 
 E   H   R   N   H   H   P   H   R   I   S   K   K   H   V   L   H   K   K    
 
AAA TGC AAA AAA TTT CTG ACC TAC TGC GCG TTT AAT GGC ATG CAT ATT CCG CTG TAA 
AAA TGC AAG AAG TTT TTG ACA AAC TGC GCT TTT AAC GGG ATG CAC ATT CCC TTA TAG 
 K   C   K   K   F   L   T   Y   C   A   F   N   G   M   H   I   P   L   * 
 
Figure 2.1 Comparison of optimized and native gene sequences encoding inflamin 
protein. The sequence of optimized synthetic gene (upper, bold) is compared to native 
cDNA sequence (lower, unbold) of inflamin. The codons that have been changed in 
optimized sequence are shown in gray boxes. Underneath the native cDNA sequence, 
protein sequence of inflamin is given with basic residues in bold which clearly 











Expected sequence of His tagged inflamin: 
MHHHHHHSSG LVPRGSSEKG RRYGEEKESL LRRSKRSKLW HPSCTCPDLN EFQHRKKHNH  
 
ACPCNGLSLH SLSEHRNHHP HRISKKHVLH KKKCKKFLTY CAFNGMHIPL  
 
Expected molecular weight of inflamin: 
Reduced inflamin - 12965.91 (with all the Cys reduced)  
Oxidized inflamin - 12959.91 (with all the Cys oxidized) 
Theoretical pI of inflamin: 10.10 
 
Figure 2.2 Schematic representation of expression constructs for inflamin. The 
restriction enzymes used for cloning the synthetic gene in pET-M are BamHI and 
XhoI. (His)6 and T represent His-tag and Thrombin cleavage site respectively. The 
amino acid residues highlighted in gray represent the extra residues added from the 
vector backbone. Six cysteine residues (Bold) present in inflamin can form three 









ampicillin and grown overnight with vigorous shaking at 37°C. Later, 1 ml culture 
was inoculated into 100 ml LB medium without ampicillin and grown to an OD600 of 
0.6-1.0 at 37°C with vigorous shaking at 200 rpm. The culture was transferred to two 
ice-cold 50 ml falcon tubes and centrifuged at 2000 g for 10 min at 4°C. After 
discarding the supernatant, the pellet was resuspended in 1 ml of 100 mM CaCl2 
followed by addition of 49 ml of 100 mM CaCl2. The cell suspension was incubated 
on ice for 40 min and centrifuged as mentioned above. The cell pellet was gently 
resuspended in 6 ml of 100 mM CaCl2 and 2 ml of autoclaved 50% glycerol. Then the 
bacterial cell suspension was aliquoted in the volume of 50 µl into pre-chilled 1.5 ml 
eppendorf tubes. The aliquoted competent cells were immediately frozen by 
immersing the tubes in liquid nitrogen. Later, the competent cells were stored at -
80°C until used. 
 
2.2.4 Heat-shock transformation 
A vial of competent cells was allowed to thaw on ice for 15 min. Then, 5 µl of 
incubated ligation mixture or 1 µl of recombinant plasmid was added to competent 
cells and placed back on ice for 30 min. The cells were incubated for 90 s at 42°C and 
immediately kept on ice for 5 min. Subsequently, 200 µl of LB broth was added to the 
cells and incubated at 37°C for 1 h with shaking at 200 rpm. Then the cells were 
plated onto LB agar plates containing 100 µg/ml ampicillin and incubated overnight 
at 37°C.  
 
2.2.5 Plasmid DNA isolation 
The plates were removed after 16 h of incubation to avoid overgrowth. Each selected 
colony was separately inoculated in 2 ml LB broth supplemented with 100 µg/ml 
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ampicillin and incubated at 37°C with shaking at 200 rpm for 16 h. Plasmid DNA was 
isolated using GeneAll™ plasmid preparation kit using the protocol recommended by 
the manufacturer. Concentration and purity of DNA were measured using the 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies) and recorded 
using the supplied software ND-1000 V3.3.0. Only 2 µl of the sample was used for 
the measurement and elution Buffer (EB) from the GeneAll™ plasmid preparation kit 
was used as a blank. 
 
2.2.6 DNA sequencing and analysis  
The nucleotide sequence of the gene was determined by ABI PRISM® Big Dye™ 
Terminator Cycle Sequencing Ready Reaction Kit (version 3.0) (PE-Applied 
Biosystems, CA, USA). Each sequencing reaction was prepared by mixing 100 ng of 
recombinant plasmid DNA, 2 μl BigDye and 1 µM of T7 promoter or terminator 
primer in a total volume of 5 μl reaction. The PCR conditions were as follows: 25 
cycles of denaturation at 96ºC for 10 s, annealing at 50ºC for 5 s and extension at 
60ºC for 4 min. The PCR amplified products were purified with CleanSEQ magnetic 
beads as recommended by the manufacturer. The purified DNA were eluted in 
autoclaved water and loaded on an automated ABI PRISM® 3130XL Genetic 
Analyzer (Applied Biosystems, Foster City, CA, USA). Analysis of the sequence data 
was carried out using Chromas 2 and GeneRunner software. 
 
2.2.7 Expression of protein 
The sequenced recombinant plasmid was transformed in E. coli SHuffle cells as 
described before. Single colony was inoculated in 100 ml LB medium containing 100 
µg/ml of ampicillin and then incubated at 37ºC overnight at 200 rpm. This culture was 
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inoculated to 1 l of LB medium containing 100 µg/ml of ampicillin and incubated at 
37ºC, 200 rpm until the OD600 reaches ~0.6. The protein expression was then induced 
with 0.1 mM IPTG (isopropyl β-D-thiogalactoside) and further incubated at 15ºC with 
shaking for 16 h before the culture was harvested. On completion of the induction 
time, the cells were harvested by centrifuging the cultures at 9,000 g for 30 min at 
4°C. The cells were washed once with MilliQ water, drained completely and then the 
cell pellets were stored at -80°C until further use. The expression of recombinant 
protein was analyzed by SDS-PAGE on a 15% polyacrylamide gel.  
 
2.2.8 Sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE) 
Bio-Rad Mini-PROTEAN™ gel system was used to run SDS-PAGE. The 12% or 
15% polyacrylamide gels were casted as indicated in Appendix (Table A.1). Samples 
were prepared by mixing 16 μl of the sample with 4 μl of 5x loading dye and 
subsequently boiled for 10 min. After spinning it in a microcentrifuge, 10 μl was 
loaded on to the gel. For the molecular weight ladder, 5 μl of Precision Plus Protein™ 
Dual-Colour Standards was run in one lane. Electrophoresis was carried out at 120 V 
until the visible marker reached near the end of the gel. The gel was stained with 
Coomassie Brilliant Blue-R250.  
 
2.2.9 Purification of protein 
Bacterial cells were thawed on ice and then the cell pellet was resuspended in cold 
lysis buffer (50 mM Tris-HCl, 150 mM NaCl, pH 8.0) by vortexing the solution. The 
ratio of cold lysis buffer to culture volume is dependent on the expression yield. The 
solution was subjected to ultrasonication (Pulse frequency: 1 s on and 2 s off) for 
about 20 min. During sonication, the solution was adequately cooled by placing the 
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tube in an ice-box. The solution was centrifuged at 40,000 g for 30 min at 4°C. 
Subsequently, the supernatant was transferred to a new tube without disturbing the 
pellet. The insoluble pellet fraction was stored at -80°C until further use. 
For extracting the protein from inclusion bodies, the insoluble pellet was resuspended 
in denaturing buffer (6 M Guanidine hydrochloride (GnHCl), 50 mM Tris-HCl, 150 
mM NaCl, pH 8.0) and the solution was kept on shaking at 4°C. After overnight 
solubilisation of pellet in the denaturing buffer, the cell debris, which could not be 
dissolved by denaturing buffer, was removed by centrifugation at 40,000 g for 30 min 
at 4°C.  
 
2.2.9.1 Affinity purification 
The Ni-NTA resin was extensively washed with MilliQ water to get rid of ethanol. 
Then the resin was either equilibrated with lysis buffer (for purification under native 
conditions) or denaturing buffer (for purification under denaturing conditions). The 
lysates were incubated with pre-equilibrated Ni-NTA resin for 1 h at 4°C with gentle 
shaking. Following incubation, the flow through was collected and wash buffer (20 
mM imidazole added to the respective equilibration buffer) was used to remove any 
non-specifically bound protein. The bound protein was eluted using a minimum 
volume of elution buffer (250 mM imidazole added to the respective equilibration 
buffer). The concentration of protein was monitored at 280 nm.  
Before running a SDS-PAGE gel for samples purified under denaturing conditions, 
these samples were subjected to trichloroacetic acid (TCA) precipitation in order to 
get rid of GnHCl which interferes while running a gel. In brief, equal volume of 
sample and 10% TCA was mixed and incubated on ice for 30 min followed by 
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centrifugation at 10,000 g for 15 min. The pellet was washed twice with ice cold 
ethanol and air dried. Finally, the pellet was dissolved in phosphate-buffered saline 
(PBS) followed by running it on the gel. 
 
2.2.9.2 RP-HPLC purification 
The protein purified by Ni-NTA chromatography under native conditions was filtered 
using a syringe filter and directly injected into Jupiter C18 column (4.6 mm X 250 
mm) attached to a AKTA purifier system (GE Healthcare Life Sciences, Piscataway, 
NJ, USA). However, the denatured eluate containing inflamin protein was completely 
reduced by incubating it with 100 mM dithiothreitol (DTT) for 2 h followed by its 
injection into Jupiter C18 column (4.6 mm X 250 mm). Solvent A (0.1% (v/v) TFA) 
and solvent B (80% (v/v) acetonitrile in 0.1% (v/v) TFA) were used for the elution of 
the protein which was monitored at 215 nm and 280 nm.  
 
2.2.10 Molecular mass determination 
The molecular mass and homogeneity of the protein sample was determined by 
electrospray ionization mass spectrometry (ESI-MS) using an API-300 LC/MS/MS 
system (PerkinElmer Life Sciences, Wellesley, MA, USA). Data was acquired in 
positive ion mode with an orifice potential of 80 V. Nitrogen was used as curtain gas 
with a flow rate of 0.6 l/min and as nebulizer gas with a pressure setting of 100 psi. A 
Shimadzu LC-10AD pump was used for solvent delivery (50% (v/v) acetonitrile in 
0.1% (v/v) formic acid) at a flow rate of 40 μl/min. Full scan data were acquired over 
the range from 1000 to 2000 m/z with step mass of 0.1 Da. Analyst software 1.4.1 
was used to analyze and deconvolute the raw mass data. Fractions showing the 
expected molecular mass were lyophilized.   
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2.2.11 Refolding of protein 
Freeze dried protein was dissolved in buffer A (0.5 M GnHCl, 10 mM EDTA, 50 mM 
phosphate, pH 8.0) to a final concentration of ~10 µM, and dialyzed for 3 days against 
the refolding buffer (0.5 M GnHCl, 0.3 M NaCl, 2 mM reduced glutathione, 1 mM 
oxidized glutathione, 5 mM EDTA, 100 mM Tris, pH 9.0) at 4°C. Then it was 
dialyzed twice against a buffer containing 0.3 M NaCl, 5 mM EDTA, 100 mM Tris, 
pH 9.0 for 12 h at 4°C. The refolded protein was purified by RP-HPLC and the 
molecular weight of the refolded protein fractions were determined by API-300 
LC/MS/MS system as mentioned above. After analyzing the mass and homogeneity 
by ESI-MS, the protein fractions eluted in the major peak were pooled and 
lyophilized. The absence of free thiol group was confirmed by Ellman assay (Ellman, 
1959). Briefly, free thiols react with 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) to 
release mixed disulfide and 2-nitro-5-thiobenzoate (TNB-), which ionizes to yellow 
coloured TNB2- at neutral or alkaline pH. The absorbance was recorded at 412 nm. 
 
2.3 Results  
2.3.1 Expression of inflamin 
Optimization of the expression in E. coli was accomplished by changing different 
parameters such as bacterial strains (BL21(DE3), Rosetta-gami(DE3) and SHuffle 
cells), IPTG concentration (0.05-1 mM), temperature (15, 20 and 37ºC) and 
incubation time (4-20 h) (results not shown). Inflamin was expressed in E. coli 
SHuffle cells, which constitutively expresses a chromosomal copy of the disulphide 
bond isomerase DsbC. The protein was expressed in soluble as well as insoluble 











Figure 2.3 15% SDS-PAGE analysis of inflamin. Samples were resolved on 15% 
SDS-PAGE gel and stained with Coomassie Brilliant Blue-R250. (A) Expression and 
solubility of inflamin in E. coli. Lane 1: Precision Plus Protein™ Dual-Colour 
Standards, Lane 2 and 3: Supernatant and pellet respectively after induction (10 μM 
IPTG), Lane 4 and 5: Supernatant and pellet respectively after induction (25 μM 
IPTG), Lane 6 and 7: Supernatant and pellet respectively after induction (50 μM 
IPTG), Lane 8: uninduced sample. (B) Expression and solubility of inflamin in E. 
coli. Lane 1: Precision Plus Protein™ Dual-Colour Standards, Lane 2: uninduced 
sample, Lane 3 and 4: Supernatant and pellet respectively after induction (100 μM 
IPTG), Lane 5 and 6: Supernatant and pellet respectively after induction (200 μM 


























No significant difference in expression was observed on changing various parameters 
such as the concentration of IPTG used, except 10 µM concentration of IPTG when 
the expression was a little less in the insoluble fraction. The yield of the protein was 
much higher from the insoluble fraction than the soluble fraction due to an unknown 
reason. So, the protein was refolded from the insoluble fraction. 
 
2.3.2 Affinity purification  
Although the expression of inflamin was less in the soluble fraction when compared 
to that in the insoluble fraction, protein was initially purified from the bacterial cell 
lysate using Ni-NTA chromatography under native conditions. Fractions from each 
step of purification were analyzed on SDS-PAGE (15% gel) as shown in Figure 2.4A. 
Eluate was having a lot of impurities along with the inflamin protein indicated in the 
box. The identity of the recombinant protein in the eluate was confirmed by peptide 
mass fingerprinting (PMF). After careful analysis of the gel, it was quite obvious that 
the protein was getting degraded during purification. This was later confirmed by 
determining the molecular mass of the degraded fragments using ESI-MS after 
purifying the Ni-NTA eluate by RP-HPLC. Protease inhibitors like AEBSF, PMSF 
and Roche complete protease inhibitor cocktail tablets were also of no help in 
preventing the degradation. This was another reason to refold the protein from 
inclusion bodies as the insoluble proteins are less susceptible to proteolytic attack.  
After extracting the insoluble proteins from inclusion bodies, the His-tagged inflamin 
was purified by Ni-NTA chromatography under denaturing conditions. The eluate 
was subjected to TCA precipitation followed by SDS-PAGE analysis. As shown in 
Figure 2.4B, the protein was almost homogenous and its yield from inclusion bodies 
was ~20 mg of denatured protein from 1 l of culture. 
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2.3.3 RP-HPLC purification 
The eluate of Ni-NTA chromatography purified under native conditions was subjected 
to RP-HPLC purification using C18 column (Figure 2.5). A sharp peak (indicated by 
arrow) corresponding to the molecular mass of inflamin protein was detected. But, the 
yield of the protein was very less because most of the protein was degraded (indicated 
by horizontal bar) and these fragments were eluted out from the RP column just 
before the elution of intact inflamin protein.  
To overcome low yield and avoid degradation problem, protein was recovered from 
the inclusion bodies. After complete reduction of the denatured protein eluate, it was 
purified by RP-HPLC (Figure 2.6A). The ESI-MS showed six peaks of mass/charge 
(m/z) ratio ranging from +7 to +12 charges (Figure 2.6B). The mass was estimated to 
be 12965.48 ± 1.03 Da (Figure 2.6B inset) exactly matching the calculated mass 
12965.91 Da. The HPLC profile and ESI-MS data confirm the homogeneity of the 
reduced protein.  
 
2.3.4 Refolding and RP-HPLC purification 
The freeze dried reduced protein was refolded using dialysis. When run on C18 
column after refolding, a major peak was obtained along with some small peaks 
(Figure 2.7A). The major peak (indicated by black arrow) was re-chromatographed on 
the same column to obtain a homogenous protein peak (Figure 2.7B). The molecular 
weight of refolded protein was determined to be 12959.07 ± 0.63 Da (Figure 2.7C). 
This suggests that all cysteine residues have been oxidized to form three disulfide 
bonds. Ellman assay confirmed the absence of free thiols in the refolded protein 








Figure 2.5 RP-HPLC profile of affinity purified recombinant protein under native 
conditions. The protein was eluted from the column with a linear gradient of 15%-
60% of solvent B (80% acetonitrile (v/v) in 0.1% (v/v) TFA) over a time period of 60 
min at a flow rate of 1 ml/min. Arrow indicates the peak for the intact inflamin 
protein and the black horizontal bar indicates the fractions containing degraded 
































Figure 2.6 Purification of reduced inflamin. (A) RP-HPLC profile of completely 
reduced and denatured inflamin extracted from inclusion bodies. The protein was 
eluted with a linear gradient of 20%-45% of solvent B over a time period of 60 min at 
a flow rate of 1 ml/min. (B) ESI-MS spectra of reduced protein showing six peaks of 
mass/charge (m/z) ratio ranging from +7 to +12 charges. The mass of reduced protein 

















































                  
 
Sample Absorbance at 412 
nm 
Conc. of free sulfhydryl 
(mM)  
Reduced protein 0.439 0.348 
Refolded protein 0 0 
 
Figure 2.7 Purification of refolded inflamin. (A) RP-HPLC profile of refolded 
inflamin. The protein was eluted with a linear gradient of 28%-38% of solvent B over 
a time period of 40 min at a flow rate of 1 ml/min. (B) RP-HPLC profile for the major 
peak on the same gradient. (C) ESI-MS spectra of refolded protein. The mass of 
refolded protein was determined to be 12959.07 ± 0.63 Da (inset). (D) Ellman assay 



































































The cDNA library revealed a novel protein sequence which intrigued us to understand 
its structure and function. The mature protein contained 94 amino acid residues 
including six cysteines and was found to be rich in basic residues   Due to low venom 
yield, recombinant protein expression system was used to get sufficient protein for its 
structural and functional characterization. A synthetic gene with preferred codons for 
E. coli was designed because eukaryotic organisms often use codons which are rarely 
used by bacterial system. It has been proven that the expression levels improve 
dramatically after codon optimization (Zhou et al., 2004) and the wide use of rare 
codons in the gene can have detrimental effects like slow translation, ribosome 
stalling and other translational errors (Kurland and Gallant, 1996).  
The optimized gene was cloned in various vectors for the recombinant expression of 
the protein. These vectors were having different solubility tags to facilitate 
overexpression of the protein. After making unsuccessful attempts with 6-7 different 
expression vectors, the optimized gene was cloned into pET-M (a modified pET-32a 
vector), devoid of thioredoxin tag (trx-tag) and S-tag. Protein was only expressed in 
the insoluble fraction when the recombinant vector was transformed in BL21(DE3) or 
Rosetta-gami(DE3) cells as a host (data not shown). But, when expressed in SHuffle 
cells, which constitutively expresses a chromosomal copy of the disulphide bond 
isomerase DsbC, inflamin was expressed in soluble fraction as well. It could be due to 
DsbC protein which is a chaperone and protein disulfide isomerase (PDI). A 
chaperone assists in protein folding and PDI assists in proper disulfide pairing. But 
unfortunately, sufficient quantity of inflamin protein could not be recovered from the 
soluble fraction due to its degradation problem. The degradation of protein was 
happening from the C-terminal as analyzed from the ESI-MS data. This is quite 
55 
 
obvious because had it been from N-terminal, it would have not been able to bind to 
Ni-NTA column as His-tag is present at N-terminal of the expressed protein. Even the 
addition of several protease inhibitors in the buffer did not increase the recovery of 
the intact protein. Only 20-30 µg of protein was obtained after final purification from 
1 l of bacterial culture. 
To increase the yield, the protein was refolded after extracting it from the inclusion 
bodies. In many cases, extraction of protein from inclusion bodies may be desirable 
because of high purity and yield of the protein. Before extraction of the protein from 
inclusion bodies, the insoluble pellet can be washed with 2 M urea buffer in order to 
remove the impurities. The refolding condition was optimized by varying different 
parameters such as pH of the buffer, molar ratio of reduced to oxidized glutathione 
and buffer components. Heavy precipitation was noticed when GnHCl was eliminated 
from the refolding buffer. For refolding, pH of the buffer should be slightly alkaline to 
allow disulfide shuffling. Variation of pH between 8-10 had almost no effect on the 
refolding of the protein. Different ratio of reduced to oxidized glutathione (2:1, 5:1, 
10:1 and 1:2) were used to improve the yield of refolded protein but no precipitation 
and higher yield was obtained when 2:1 ratio was used. After purification of the 
refolded protein, approximately 1.5 mg of the major peak containing refolded 
inflamin was obtained from 1 l of bacterial culture. The other peaks were freeze dried, 
reduced and refolded again. 
The inflamin protein was quite stable after refolding. After lyophilization of the major 






Recombinant expression was used to obtain protein in milligram quantity for 
determining its structure and function. This chapter describes the experimental 
designs and results of recombinant protein expression in bacterial system. Several 
vectors and bacterial hosts were tried before choosing SHuffle cells containing 
recombinant pET-M for protein expression. Inflamin protein was successfully 
expressed and refolded for its structural and functional studies detailed in subsequent 
chapters. In future, if required, mutagenesis studies can be conducted using the 
established recombinant expression system of inflamin to understand its structure-













































Functional characterization of inflamin 
3.1 Introduction 
No conserved domain or significant sequence alignment was obtained when inflamin 
sequence was used for similarity search against the protein database by BLAST. Thus, 
we had absolutely no idea what function this protein could have. But, the sequence 
was found to be rich in basic residues (13 lysine and 8 arginine residues). Cytotoxins 
are highly basic proteins (approx. 9-12 lysine and arginine residues), which are 
abundant in the venom of the snakes of the elapidae family. These proteins are 
hemolytic, cytotoxic and are capable of depolarizing membranes of myofibrils 
(Dufton and Hider, 1988; Fletcher et al., 1996). It has been speculated that cytotoxins 
interact with lipids and biological membranes by a proper combination of 
hydrophobic and electrostatic forces (Vincent et al., 1978). Initially, using this 
information, we checked the hemolytic activity of the protein. 
To identify the pharmacological symptoms induced by the protein, we injected the 
refolded protein intraperitoneally into the mice. It induced writhing responses but 
none of the mice died within 24 h. Writhing means to make twisting movements 
which is due to contraction of abdominal musculature. It is a sign of abdominal pain 
which happens due to the release of prostanoids in the peritoneal cavity. Prostanoids 
are the lipid mediators derived from arachidonic acid. The best known function for 
prostanoids in cells is that they modify the inflammatory response, affecting 
symptoms, such as fever, pain and swelling. Prostanoids level in cells are low under 
normal conditions, but during inflammation both the nature and concentration of 
prostanoids can change noticeably.  
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Both COX-1 and COX-2 enzymes can convert arachidonic acid into prostanoids. But, 
COX-1 is a constitutive enzyme and COX-2 is an inducible enzyme. To delineate the 
mechanism of action, we have investigated the role of COX isoforms as they provide 
the substrate for the formation of prostanoids inside the cell. COX enzymes catalyze 
an essential step in the prostanoids biosynthetic pathway. Thus, we have checked the 
effect of inflamin on expression level and enzymatic activity of both the COX 
isoforms.  
We have also investigated the source of arachidonic acid. As shown in Figure 1.7, 
PLA2 and DAG (diacylglycerol) lipase can synthesize arachidonic acid. Phospholipids 
are converted by phospholipase C (PLC) or by the combined action of phospholipase 
D (PLD) and phosphatidic acid phosphatase-1 (PAP-1) into DAG, which is later 
converted to arachidonic acid by DAG lipase (Figure 3.1). Therefore, we have used 
several inhibitors to determine the pathway which actively contributes in the 
generation of arachidonic acid. Later, we have also determined the effect of inflamin 
on the enzymatic activity and post-translational modification of cPLA2 enzyme, 
which generates arachidonate on inflamin administration. Thus, this chapter talks 
















Figure 3.1 Arachidonate biosynthetic pathway. The release of arachidonic acid can 
occur via two pathways, by liberation of arachidonate from phospholipids by a PLA2 
or by the action of DAG lipase. DAG: Diacylglycerol, PC: Phosphatidylcholine, PE: 
Phosphatidylethanolamine, PIP2: Phosphatidylinositol 4,5-bisphosphate, PAP-1: 
Phosphatidic acid phosphatase-1. 






















3.2 Materials and Methods 
3.2.1 Materials 
RAW 264.7 cell line was purchased from American Type Culture Collection 
(Manassas, VA, USA). Indomethacin, Dulbecco's Modified Eagle's Medium 
(DMEM), Polyvinylidene Difluoride (PVDF) membrane and Penicillin-Streptomycin 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). CellTiter 96 AQueous One 
Solution Cell Proliferation Assay was purchased from Promega Corporation 
(Madison, WI, USA). Anti-COX-1, anti-COX-2 and anti-rabbit antibodies, PGE2, 6-
keto PGF1α, PGF2α, TXB2 and PGD2 EIA kits, COX and cPLA2 assay kits were 
purchased from Cayman Chemical (Ann Arbor, MI, USA). Anti-β-actin, anti-cPLA2 
and anti-phospho-cPLA2 (Ser505) antibodies were purchased from Cell Signaling 
Technology (Danvers, MA, USA). RHC 80267 and YM 26734 were purchased from 
Tocris Bioscience (Bristol, UK). AACOCF3 and PACOCF3 were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Pierce ECL Western Blotting 
Substrate was purchased from Thermo Fisher Scientific (Rockford, IL, USA). All 
other chemicals and reagents used were of analytical grade. 
 
3.2.2 Hemolytic assay 
Hemolytic activity of inflamin was assayed as described previously (Chen et al., 
1997). Blood from healthy human volunteers was collected into a solution of 3.8% 
sodium citrate (9:1, v/v) and centrifuged for 10 min at 800 g at room temperature. The 
plasma was discarded and red blood cells (RBCs) were washed three times with 
saline. Various concentration of protein samples were incubated with 2% (v/v) final 
concentration of RBCs resuspended in 1 ml saline for 1 h at 37°C (n = 3). For 
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negative control, no protein was added. RBCs resuspended in MilliQ water served as 
a positive control. RBCs were removed by centrifugation at 800 g for 10 min at room 
temperature, and the absorbance of the supernatant was read at 540 nm. Hemolytic 
levels were expressed as percentage of hemolysis, calculated using the ratio between 
the value measured for each sample and that registered for the positive control.   
 
3.2.3 Animals 
Animals (Swiss albino mice and Sprague Dawley rats) were obtained from the 
National University of Singapore Laboratory Animal Centre and acclimatized to the 
Laboratory Animal Holding Unit for at least three days before the experiments. The 
animals were kept under standard conditions with food and water available ad libitum 
in a light-controlled room (12 h light/dark cycle, light on 07:00 h) at 23°C and 60% 
relative humidity. All the animal experiments were conducted in accordance to the 
protocol (021/07) approved by the Institutional Animal Care and Use Committee of 
the National University of Singapore.  
 
3.2.4 In vivo effects of inflamin 
3.2.4.1 Writhing induced by inflamin  
Inflamin (dissolved in 200 µl saline) was injected intraperitoneally (i.p.) using 27-
gauge 1/2” needle (Becton-Dickinson, Franklin Lakes, NJ, USA) in a male Swiss 
albino mice (18 ± 2 g) at various doses (n = 3). Control group was injected with 200 
µl of saline. The mice were placed in the cage and numbers of writhing reaction were 
recorded for 30 min. In separate experiments, indomethacin, 10 mg/kg, was 




3.2.4.2 Effect of inflamin on prostanoid synthesis 
In separate experiments, at selected time intervals after the intraperitoneal injection, 
the mice were euthanized by exposure to carbon dioxide and the peritoneal exudates 
were withdrawn after washing and massaging the peritoneal cavities with 2 ml of 
phosphate-buffered saline (PBS) containing 10 µM indomethacin (n = 3). The 
exudates were centrifuged at 500 g for 10 min at 4ºC and supernatants were stored at -
80ºC and later used for the determination of the prostanoids concentration by a 
specific enzyme immunoassay (EIA) (described below). In a different experiment, 10 
mg/kg indomethacin was intraperitoneally injected 30 min before the protein injection 
followed by the same procedure as discussed above in this paragraph (n = 3). 
 
3.2.4.3 Edema induced by inflamin 
Inflamin (dissolved in 50 µl saline) was injected in the subplantar region of the right 
hind paw of the rats (220 ± 20 g) (n = 3). The left hind paw received an equal volume 
of saline alone and served as a control. The increased volume of the hind paw was 
measured by dipping the foot up to the lateral malleolus in a measuring cylinder 
containing water at specific time points.  
 
3.2.5 Cell culture 
The murine macrophage cell line, RAW 264.7, was maintained in Dulbecco modified 
essential medium supplemented with 1 mg/ml glucose, 10% FBS, 100 U/ml 
penicillin, and 100 µg/ml streptomycin at 37°C with 5% CO2. The cells were sub-
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cultured every three days. The cells at passage number 10 or less were used for the 
experiments.  
 
3.2.6 Cell viability assay  
Cell viability was assessed by CellTiter 96 AQueous One Solution Cell Proliferation 
Assay. Briefly, 4 X 103 RAW 264.7 cells in 80 µl were incubated with 20 µl of the 
protein in DMEM or DMEM alone (control) for 24 h at 37ºC in a humidified 
atmosphere of 5% CO2 (n = 4). Then, 20 µl of AQueous One Solution Reagent (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium; MTS and phenazine ethosulfate; PES) was added into each well and 
incubated for 2 h at 37ºC in a humidified atmosphere of 5% CO2. The absorbance of 
the soluble MTS formazan product was recorded at 490 nm by 96-well microplate 
reader (Tecan Sunrise, Männedorf, Switzerland). Results were expressed as 
percentage of viable cells. 
 
3.2.7 Prostanoids assay 
RAW 264.7 cells (1 × 105 cells/well) were seeded in 24-well plates and incubated for 
24 h. Cells were treated with 10 µM (unless mentioned otherwise) of inflamin for 
specific time intervals and then supernatants were collected (n = 3). The 
concentrations of prostanoids in peritoneal exudates and cell culture supernatants 
were determined by a specific EIA kit according to the manufacturer’s instructions. In 
brief, 50 µl aliquots of each sample were incubated with 50 µl solution of prostanoids 
conjugated with acetylcholinesterase along with 50 µl of specific antiserum against 
prostanoids in 96-well plates, coated with secondary antibody. After the overnight 
incubation, the wells were emptied and washed five times with wash buffer. 
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Subsequently, 200 µl of substrate containing acetylthiocholine and DTNB was added 
to each well followed by 1-2 h incubation for colour development. The absorbance of 
yellow coloured TNB2- was recorded at 405 nm.  
In separate experiments, to understand the role of various enzymes (phospholipase A2 
(PLA2) enzymes and diacylglycerol (DAG) lipase), cells were pre-treated with 
specific inhibitors of these enzymes such as RHC 80267 (DAG lipase, 10 µM), YM 
26734 (sPLA2, 10 µM), AACOCF3 (cPLA2, 20 µM) or PACOCF3 (iPLA2, 4 µM) for 1 
h before the protein treatment (n = 3). Then, the supernatants were used for the 
determination of 6-keto PGF1α concentration using the method described above.  
 
3.2.8 COX enzymatic activity assay 
RAW 264.7 cells (2 X 107 cells) were sonicated in 100 µl of cold lysis buffer (0.1 M 
Tris-HCl, pH 7.8 containing 1 mM EDTA) and then centrifuged at 10,000 g for 15 
min at 4ºC. The supernatant was stored on ice for the COX activity assay. COX 
activity, in the presence of specific inhibitors of COX-1 (SC-560) or COX-2 (DuP-
697), was determined spectrophotometrically using a commercial kit (Cayman 
Chemical) (n = 3). In brief, 5 µl aliquots of each sample were incubated with 0.5 µM 
heme for 5 min, and then 10 µM TMPD (N,N,N’,N’-tetramethyl-p-
phenylenediamine) and 100 µM arachidonic acid were added. The reaction was 
allowed to develop for 5 min at room temperature and then the absorbance of oxidized 







3.2.9 Western blotting  
RAW 264.7 cells (1 X 106 cells) were lysed with 100 µl of lysis buffer (50 mM Tris, 
pH 7.4, 300 mM NaCl, 5 mM EDTA, pH 8.0, 0.5% Triton X-100, 1 mM aprotinin, 1 
mM leupeptin, 1 mM pepstatin, 1 mM sodium orthovandate and 1 mM 4-(2-
aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF)). The cell lysates were 
centrifuged at 12,000 g at 4ºC for 15 min and supernatants were transferred to new 
tubes. Protein concentrations were determined using Bio-Rad Protein Assay (Bio-
Rad, Hercules, CA, USA). Aliquots of the lysates (20-30 µg of protein) were resolved 
on a 12% SDS-PAGE under reducing conditions and transferred onto a PVDF 
membranes by Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad, 
Hercules, CA, USA) using a glycine transfer buffer (192 mM glycine, 25mM Tris-
HCl (pH 8.8), 20% methanol (v/v)). Before blotting, PVDF membranes were 
activated by placing it in methanol for 2 min. The protein transfer was carried out at 
15 V for 45 min. Subsequently, the membranes were blocked with PBS-T (PBS, pH 
7.4, 0.1% Tween-20) containing 5% skim milk for an hour and probed with respective 
primary antibodies against cPLA2 (1:1,000), phospho-cPLA2 (1:1,000), COX-1 
(1:1,000), COX-2 (1:200) and β-actin (1:5,000) in PBS-T solution containing 5% 
skim milk for 3-4 h. After washing five times with PBS-T solution, the membranes 
were exposed to HRP-conjugated goat anti-rabbit IgG (1:10,000) in PBS-T solution 
containing 5% skim milk for 1 h. Subsequently, the membranes were washed with 
PBS-T for five times and the detection was performed using the ECL Western 






3.2.10 cPLA2 enzymatic activity assay 
RAW 264.7 cells (1 X 107 cells) were sonicated in 200 µl of cold lysis buffer (0.1 M 
Tris-HCl, pH 7.8 containing 1 mM EDTA) and then centrifuged at 10,000 g for 15 
min at 4ºC. The cPLA2 activity in the supernatant was measured according to the 
protocol recommended by the manufacturer (Cayman Chemical) (n = 4). In brief, 10 
µl aliquots of each supernatant were added to 96-well plates together with 5 µl of 
assay buffer (80 mM HEPES, pH 7.4, 150 mM NaCl, 10 mM CaCl2, 4 mM Triton X-
100, 30% glycerol, and 1 mg/ml BSA). The reaction was initiated by the addition of 
200 µl of substrate arachidonoyl thio-phosphatidylcholine to each well, incubated for 
60 min at room temperature, and stopped by the addition of 10 µl of 25 mM 5,5’-
dithio-bis(2-nitrobenzoic acid) (DTNB) and 475 mM ethylene glycol-bis(2-
aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA) mixture in 0.5 M Tris-HCl (pH 
8.0). The reaction was allowed to develop for 5 min at room temperature and then the 
absorbance of yellow coloured TNB2- was measured at 405 nm.  
   
3.3 Results  
3.3.1 Hemolytic activity 
Blood collected was centrifuged to remove the plasma and the RBCs were washed 
three times with saline. To determine the hemolytic activity, the RBCs were treated 
with inflamin at concentrations ranging from 1 to 100 μM. The protein was found to 
be weakly hemolytic, as only 21% hemolysis was observed at 100 μM inflamin 





3.3.2 Inflamin induces inflammation 
To examine the toxicity and identify pharmacological symptoms induced by inflamin, 
the refolded protein was injected into one mouse each at 10 mg/kg, 50 mg/kg and 100 
mg/kg doses. All of them showed writhing responses but none of the mice died within 
24 h. This indicated that inflamin is non-toxic and induces writhing. In separate 
experiments, dose- and time-dependent writhing responses in mice was further 
examined. Intraperitoneal injection of inflamin resulted in dose-dependent increase in 
writhing (stretching) responses in mice, and the number of responses that occurred 
during each sequential 5 min periods for a total of 30 min were counted (Figure 3.3). 
The number of responses peaked in 5-10 min period and ceased within 30 min of the 
protein injection. However, two different conformers of inflamin (10 mg/kg, i. p.), as 
shown in Figure 2.7A (indicated by open arrows), did not induce writhing in mice 
indicating proper folding is important for its ability to induce writhing. 
In general, writhing responses are due to pain and inflammation. Therefore, the edema 
inducing activity of inflamin in rats was examined. Intraplantar injection of inflamin 
caused time- and dose-dependent increase in the paw volume until 2 h after the 
injection, which was followed by gradual decrease in the paw volume (Figure 3.4). 
Taken together, these results suggest that inflamin induces edema and inflammation 
leading to pain in experimental animals.  
To determine the role of cyclooxygenases and production of prostanoids in the 
inflammation induced by inflamin, the effect of indomethacin, a non-specific inhibitor 
of cyclooxygenases, was examined. Indomethacin treatment significantly reduced the 
number of writhing reactions induced by the intraperitoneal injection of inflamin, 




    
Figure 3.2 Hemolytic activity of inflamin. The RBCs were treated with 1 to 100 µM 
of inflamin. Each data point represents mean ± SD (n = 3).   
 
      
Figure 3.3 Writhing response induced by intraperitoneal injection of different doses 
of inflamin. Frequency of the writhing response was counted in each of the six 
sequential 5-min periods immediately after the injection of the protein into the mice. 
The number of responses peaked in 5-10 min period and the dose-dependent increase 


























   
   














       
Figure 3.4 Edema induced by intraplantar injection of various doses of inflamin. Rats 
were injected with inflamin in the right footpad and with saline in the left footpad. 
The increased volume of the hind paw was measured at specific time points. Increase 
in the paw volume was noticed until 2 h after the injection, which was followed by 
gradual decrease in edema. Each data point represents mean ± SD (n = 3).    
   
       
Figure 3.5 Effect of indomethacin on writhing response induced by inflamin. 
Indomethacin pre-treatment significantly reduced the frequency of writhing responses 
induced by inflamin, therefore indicating the involvement of cyclooxygenases. Each 



















   
   
   







   
   














3.3.3 Inflamin induces prostanoids release in the peritoneal cavity    
Indomethacin pre-treatment reduced the number of writhing responses induced by 
inflamin, clearly indicating the involvement of cyclooxgenases and release of 
prostanoids in the peritoneal cavity. Thus, to identify the mediators responsible for the 
writhing responses induced by inflamin, the mice were euthanized at selected time 
intervals after the intraperitoneal injection of an inflammatory dose of inflamin (10 
mg/kg) and the peritoneal exudates were withdrawn, which were subsequently used 
for the determination of concentration of prostanoids such as prostanglandin E2 
(PGE2) (Figure 3.6A), 6-keto prostaglandin F1α (6-keto PGF1α) (Figure 3.7A), 
prostaglandin F2α (PGF2α) (Figure 3.8A), thromboxane B2 (TXB2) (Figure 3.9A), 
prostaglandin D2 (PGD2) (Figure 3.10A). The levels of prostanoids peaked at 10 min 
after injection which corresponded well to the peak of writhing responses as shown in 
Figure 3.3. 6-keto PGF1α showed the highest level among the prostanoids at 10 min 
after the injection. Inflamin induced 7-, 7-, 4-, 2- and 1.5-fold increment in PGE2, 6-
keto PGF1α, PGF2α, TXB2 and PGD2 levels respectively at 10 min after the injection 
when compared to control. The levels of 6-keto PGF1α, PGE2 and TXB2 subsided 
quickly with time and PGF2α level decreased gradually. But, the level of PGD2 did not 
subside with time. The gradual increase in PGE2 and 6-keto PGF1α level was observed 
between 2 and 4 h after the injection of the inflamin which marks the onset of second 
wave of prostanoids formation. But, the total amount of prostanoids released at 10 
min was much higher than that released at 6 h after the inflamin injection. 
Since the release of prostanoids peaked at 10 min after injection, the concentration of 
prostanoids induced by different doses of inflamin at that particular time was 
determined (Figure 3.6B-3.10B). Inflamin induced dose-dependent increase in all the 
prostanoids assayed. At 1 mg/kg dose of inflamin, increase in PGE2, 6-keto PGF1α, 
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PGF2α, TXB2, PGD2 levels were 169%, 334%, 55%, 2% and 6% respectively. 
Remarkable increment of 110-fold was observed for 6-keto PGF1α at 100 mg/kg dose 
when compared to control (Figure 3.7B). The proportion of 6-keto PGF1α production 
among the prostanoids was much higher at any dose of inflamin.  
To ascertain the role of prostanoids in writhing induced by inflamin, effect of 
indomethacin on prostanoids production was investigated. Indomethacin pre-
treatment suppressed the production of prostanoids induced at 10 min after the 
injection of 10 mg/kg inflamin (Figure 3.11). Inhibition of COX enzymes by 
indomethacin lowers the production of prostanoids induced by inflamin in such a way 
that it becomes comparable to that of control. Consequently, the frequency of writhing 
response was reduced significantly.  
 
3.3.4 Production of 6-keto PGF1α by RAW264.7 cells      
To understand and investigate the mechanism of action, RAW264.7 cells were 
cultured. The toxicity of inflamin on RAW264.7 cells was checked by performing the 
cell viability assay. Different doses of inflamin were administered to RAW264.7 cells 
and it was found to be cytotoxic at concentration higher than 30 µM (Figure 3.12). 
Since 6-keto PGF1α level was highest among the prostanoids released in the peritoneal 
cavity, we monitored only 6-keto PGF1α for the rest of the experiments on cultured 
cells. At 10 µM inflamin, the sub-cytotoxic concentration, the production of 6-keto 
PGF1α peaked at 10 min and then subsided until the second wave of prostaglandin 
production was marked by an increase in 6-keto PGF1α levels from 3 h up to 12 h 









Figure 3.6 Production of PGE2 in the peritoneal cavity. (A) Time-dependent 
production of PGE2 in the peritoneal cavity following the intraperitoneal injection of 
10 mg/kg dose of inflamin (bold line) or saline (dotted line). First wave of PGE2 
production was seen at 10 min and the onset of second wave was only observed after 
2 h.  (B) Dose-dependent production of PGE2 in the peritoneal cavity at 10 min after 
the intraperitoneal injection of various doses of inflamin. Each data point represents 
















   
   







   
   













Figure 3.7 Production of 6-keto PGF1α in the peritoneal cavity. (A) Time-dependent 
production of 6-keto PGF1α in the peritoneal cavity following the intraperitoneal 
injection of 10 mg/kg dose of inflamin (bold line) or saline (dotted line). First wave of 
6-keto PGF1α production was seen at 10 min and the onset of second wave was 
observed after 1 h. The 6-keto PGF1α level was highest among the prostanoids at 10 
min. (B) Dose-dependent production of 6-keto PGF1α in the peritoneal cavity at 10 
min after the intraperitoneal injection of various doses of inflamin. Each data point 

















   
   











   
   

















Figure 3.8 Production of PGF2α in the peritoneal cavity. (A) Time-dependent 
production of PGF2α in the peritoneal cavity following the intraperitoneal injection of 
10 mg/kg dose of inflamin (bold line) or saline (dotted line). The level of PGF2α 
peaked at 10 min and gradually decreased with time but even at 6 h after injection, 
inflamin-induced PGF2α level was more than twice the control level. (B) Dose-
dependent production of PGF2α in the peritoneal cavity at 10 min after the 
intraperitoneal injection of various doses of inflamin. Each data point represents mean 

















   
   







   
   













Figure 3.9 Production of TXB2 in the peritoneal cavity. (A) Time-dependent 
production of TXB2 in the peritoneal cavity following the intraperitoneal injection of 
10 mg/kg dose of inflamin (bold line) or saline (dotted line). The level of TXB2 
peaked at 10 min and subsided quickly to go below the control level. (B) Dose-
dependent production of TXB2 in the peritoneal cavity at 10 min after the 
intraperitoneal injection of various doses of inflamin. Each data point represents mean 















   
   








   
   














Figure 3.10 Production of PGD2 in the peritoneal cavity. (A) Time-dependent 
production of PGD2 in the peritoneal cavity following the intraperitoneal injection of 
10 mg/kg dose of inflamin (bold line) or saline (dotted line). The PGD2 level also 
showed sudden increase in its concentration like other prostanoids but it did not 
subside with time. (B) Dose-dependent production of PGD2 in the peritoneal cavity at 
10 min after the intraperitoneal injection of various doses of inflamin. Each data point 















   
   







   
   













Figure 3.11 Effect of indomethacin on prostanoids production induced by inflamin. 
Indomethacin pre-treatment significantly suppressed the production of prostanoids at 
10 min after the intraperitoneal injection of 10 mg/kg inflamin, therefore indicating 
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Figure 3.12 Effect of inflamin on cell viability in RAW264.7 macrophages. The MTS 
assay was performed after incubating RAW264.7 cells with various concentrations of 
inflamin for 24 h at 37ºC in 5% CO2. Inflamin was found to be cytotoxic at 
concentration higher than 30 µM. Each data point represents mean ± SD (n = 4). 
 
Figure 3.13 Effect of inflamin on 6-keto PGF1α production in RAW264.7 
macrophages. The supernatants collected following the inflamin (bold line) or saline 
(dotted line) treatment were subjected to 6-keto PGF1α enzyme immunoassay. Each 
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Thus, due to coherent profile of 6-keto PGF1α from both cell culture and peritoneal 
exudates, RAW264.7 cells can be used as a model to study the mechanism of action 
of inflamin protein. 
 
3.3.5 Effect of inflamin on COX enzymatic activity and expression    
To delineate the mechanism and understand the role of COX enzymes in the 
prostanoids production, RAW264.7 cells were incubated with the sub-cytotoxic 
concentration of inflamin for different time intervals followed by analysis of COX-1 
and COX-2 enzymatic activity. The COX-1 activity increased by 46% at 10 min in 
comparison to control but remained almost comparable to control at other time points 
(Figure 3.14A). However, COX-2 activity was detected only after 3 h, with a peak at 
12 h after inflamin administration (Figure 3.14B).  
To examine the expression level of COX-1 and COX-2 enzyme with time, RAW264.7 
cells were treated with inflamin followed by western blot analysis. Inflamin 
administration did not influence the expression of COX-1 enzyme (Figure 3.15). On 
the other hand, COX-2 expression was induced at 3 h, with a peak at 12 h after the 
incubation (Figure 3.15). The events which lead to an increase in COX-1 activity 
observed at 10 min after the inflamin administration is still unclear. But, COX-1 is 
definitely responsible for the first wave of prostanoids production as COX-2 is only 
induced at 3 h after inflamin administration. 
 
3.3.6 Effect of inhibitors on 6-keto PGF1α production by RAW264.7 cells 
Arachidonic acid, which is converted to prostanoids by COX enzyme, can be either 
generated by phospholipase A2 (PLA2) enzyme or diacylglycerol (DAG) lipase. PLA2 
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enzyme acts on phospholipids, such as phosphatidylcholine or 
phosphatidylethanolamine, to release arachidonic acid. However, DAG lipase cleaves 
DAG generated by phospholipase C (PLC) enzyme or combined action of 
phospholipase D (PLD) and phosphatidate phosphatase-1 (PAP-1) to yield 
arachidonic acid. In order to understand the mechanism of arachidonic acid 
generation, four inhibitors RHC 80267, YM 26734, AACOCF3 and PACOCF3 were 
used against DAG lipase, secretory PLA2 (sPLA2), calcium-dependent PLA2 (cPLA2) 
and calcium-independent PLA2 (iPLA2) respectively. Inflamin was incubated with 
RAW264.7 cells in presence of inhibitors for 10 min followed by quantification of 6-
keto PGF1α in supernatants collected. Inhibition of cPLA2 enzyme by AACOCF3 
significantly reduced 6-keto PGF1α production induced by inflamin (60% reduction), 
in comparison with control (Figure 3.16A). In contrast, inhibition of iPLA2, sPLA2 
and DAG lipase did not change 6-keto PGF1α production significantly. Thus, cPLA2 
enzyme plays a key role in the production of arachidonate. 
 
3.3.7 Effect of inflamin on cPLA2 enzymatic activity, expression and 
phosphorylation  
AACOCF3 significantly inhibited the 6-keto PGF1α production induced by inflamin 
which led us to examine the cPLA2 enzymatic activity. The cPLA2 activity was 
measured after incubating the cells with 10 µM inflamin for different time intervals. 
The cPLA2 activity peaked at 10 min with 62% increase in the activity compared to 
the control and a drop in its activity was noticed after 30 min (Figure 3.16B). This 
clearly indicates that inflamin induces cPLA2 activation resulting in the increased 
production of arachidonate, which is further converted to prostanoids by the action of 







Figure 3.14 Effect of inflamin on enzymatic activity of COX-1 and COX-2 in 
RAW264.7 macrophages. Cells were incubated with inflamin (bold line) or saline 
(dotted line). After selected time intervals, COX-1 (A) and COX-2 (B) enzymatic 
activities were determined spectrophotometrically in the presence of COX-1 and 
COX-2 specific inhibitors. Each data point represents mean ± SD (n = 3). *p < 0.05 
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Figure 3.15 Effect of inflamin on the expression of COX-1 and COX-2 enzyme in 
RAW264.7 macrophages. (A) Western blotting of COX-1, COX-2 and β-actin after 
incubating the cells with inflamin for selected time intervals. Bar graph shows the 
densitometric analysis of immunoreactive COX-1 (B) and COX-2 (C) band intensities 
normalized to β-actin. Results are expressed as mean ± SD (n = 3). *p < 0.05 when 



















Saline 5 min 10 min 20 min 0.5 h 1 h 3 h 6 h 12 h
   
   












   
   















Figure 3.16 Arachidonate production in macrophages. (A) Effect of inhibitors of 
DAG lipase, sPLA2, cPLA2 and iPLA2 on inflamin-induced 6-keto PGF1α production. 
Inflamin was incubated with RAW264.7 cells in presence of inhibitors for 10 min 
followed by quantification of 6-keto PGF1α in supernatants. Results are expressed as 
mean ± SD (n = 3). *p < 0.05 when compared with the vehicle (inflamin without 
inhibitor). (B) Effect of inflamin on cPLA2 activity in RAW264.7 macrophages. The 
cPLA2 activity was determined after incubating the cells with 10 µM inflamin for 
different time intervals. Results are expressed as mean ± SD (n = 4). *p < 0.05 when 
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Figure 3.17 Effect of inflamin on the expression and phosphorylation of cPLA2 
enzyme in RAW264.7 macrophages. (A) Western blotting of cPLA2, P-cPLA2 and β-
actin after incubating the cells with inflamin for selected time intervals. Bar graph 
shows the densitometric analysis of immunoreactive cPLA2 (B) and P-cPLA2 (C) 
band intensities normalized to β-actin. Results are expressed as mean ± SD (n = 3). *p 



















   
   











   














To study the mechanism of cPLA2 activation, we examined the expression and post-
translational modification of cPLA2 enzyme. RAW264.7 macrophages were incubated 
with inflamin followed by western blot analysis. Our results show that inflamin does 
not have any effect on cPLA2 expression. But, the enzyme was found to be 
phosphorylated at Ser505 within 5 min of inflamin administration which was 
detectable until 1 h (Figure 3.17). Hence, inflamin induces the phosphorylation of 





















3.4 Discussion  
Cytotoxins are highly basic proteins (approx. 9-12 lysine and arginine residues) that 
show hemolytic or cytolytic activity. For the activity of cytotoxins, basic amino acid 
residues seem to be important for their interaction with negatively charged lipids 
(Kini and Evans, 1989; Shai et al., 1991; Maloy and Kari, 1995; Blondelle and 
Houghten, 1991; Chen et al., 1997). Being rich in cationic amino acid residues, 
hemolytic activity of inflamin was checked. But, our results suggest that it is weakly 
hemolytic.  
Intraperitoneal injection of inflamin induces writhing reaction in experimental 
animals but no lethality was observed at the doses studied. Within 2-3 min after the 
injection, the animals start exhibiting a unique posture with their neck twisted and 
their body following the neck to complete a full turn around the body axis which is 
known as writhing response. The frequency of writhing reactions peaked during 5-10 
min period after the inflamin injection and the writhing response lasted about 30 min. 
Also the dose-dependent increase in writhing responses was observed. Indomethacin 
pre-treatment significantly reduced the frequency of writhing induced by inflamin 
indicating the production of prostanoids in the peritoneal cavity that induces the 
animal to writhe in pain. Flammutoxin, a cardiotoxic protein isolated from the edible 
mushroom Flammulina velutipes, shows a strong hemolytic activity, induces severe 
edema on intraplantar injection and induces writhing reaction upon intraperitoneal 
injection (Lin et al., 1975). Upon flammutoxin injection, maximal writhing was 
observed at 4 min after the injection and writhing response lasted about 12 min. 
Bestoxin, a novel toxin containing 58 amino acid residues and three disulfide bridges 
isolated from the venom of South African scorpion Parabuthus transvaalicus, induces 
intense writhing in injected animals (Inceoglu et al., 2005). After bestoxin injection, 
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severity of writhing responses increases with time and even after 24 h post-injection, 
the test animals continue to writhe albeit exhausted. Therefore, inflamin behaves in a 
different way in comparison to bestoxin and flammutoxin. 
Writhing response is a pharmacological symptom of pain and inflammation. Further 
investigating inflammation induced by inflamin, we observed time- and dose-
dependent increase in edema until 2 h followed by gradual decrease in edema. Thus, 
our results indicate that inflamin induces inflammation leading to pain in the 
experimental animals.  
Intraperitoneal injection of inflamin induced prostanoids (PGE2, 6-keto PGF1α, PGF2α, 
TXB2, PGD2) production in the peritoneal cavity. The concentration of prostanoids 
rose rapidly and peaked at 10 min after the inflamin injection which corresponded 
well with the peak of writhing responses. This is in contrast to zymosan-induced 
PGE2 production that rose quickly following injection, to reach a peak at 30 min after 
injection, which corresponded well with the peak of writhing responses observed in 
between 15 and 30 min, followed by a gradual decline in PGE2 level (Doherty et al., 
1985). Interestingly, the level of 6-keto PGF1α, a stable product of prostacyclin 
(PGI2), was much higher when compared to other prostanoids produced at 10 min 
after inflamin injection (Figure 3.18). As reported previously, PGI2 is one of the main 
metabolite involved in the writhing response (Berkenkopf and Weichman, 1988; 
Murata et al., 1997) and its receptor, known as prostacyclin receptor (IP receptor), has 
a major role to play in endotoxin-induced pain perception (Ueno et al., 2001). Thus, 
we infer that the writhing response induced by inflamin is due to the biosynthesis of 
PGI2 in huge quantity that activates IP receptor on binding. The second wave of PGE2 
and 6-keto PGF1α production was observed at 2 h after the injection. Inflamin induced 
the dose-dependent increment in all the prostanoids estimated. A remarkable increase 
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in 6-keto PGF1α level of 3.5 fold and 110 fold at 1 mg/kg and 100 mg/kg respectively 
was observed in comparison to control. At any dosage, 6-keto PGF1α level was much 
higher among all the prostanoids. Thus, owing to differential conversion of common 
precursor PGH2 into various prostanoids, the possibility that the stimulatory effect of 
inflamin on prostanoids production may also be due to its effects on different terminal 
PG-synthases coupled to COX enzymes cannot be ruled out. As reported previously, 
COX-1 enzyme and PGI2 synthase colocalize at the nuclear envelope and 
endoplasmic reticulum of cultured endothelial cells which is found to be critical for 
the synthesis of prostacyclin (Liou et al., 2000). Thus, we speculate that COX enzyme 
is colocalized or is in close proximity to PGI2 synthase. 
Indomethacin pre-treatment significantly reduced the level of prostanoids at 10 min 
after the intraperitoneal injection of inflamin (10 mg/kg) that was reflected by 
reduction in numbers of writhing responses between 5-10 min. This further 
corroborates that writhing induced by inflamin is solely the result of prostanoids 
production in the peritoneal cavity.   
RAW264.7 macrophages were cultured to understand the mechanism of prostanoids 
production. COX-1 activity increased at 10 min after the administration of inflamin 
with no change in expression level throughout the time. The mechanism of increase in 
its activity is presently unknown but it is unquestionably responsible for the 
production of huge amounts of prostanoids at 10 min as COX-2 enzyme is only 
induced at 3 h after inflamin administration. However, COX-2 expression at 3 h after 
inflamin administration marked the advent of second wave of 6-keto PGF1α 
production. Intraperitoneal injection of phenylquinone in mice induced writhing for 
up to 30 min and highest 6-keto PGF1α level was noticed at 15 min after the injection. 
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Figure 3.18 Comparison of prostanoids production induced at 10 min and 6 h following inflamin or saline injection. Inflamin induced majority 
of the PGH2 liberated from arachidonate to be shunted towards PGI2 formation at 10 min. However, at 6 h after the injection, 6-keto PGF1α level 
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The report concludes that prostanoids involved in phenylquinone-induced writhing 
was formed by COX-1 enzyme as COX-2 was induced at 60 min after injection 
(Kusuhara et al., 1998). Our finding strongly suggest that COX-1 enzyme catalyzes 
arachidonic acid during the first wave of prostanoids production but later COX-2 
induction brings upon the second wave of prostanoids production.    
Crotoxin B (CB), a neurotoxic and myotoxic sPLA2 from the venom of Crotalus 
durissus terrificus, does not induce the expression of COX-2 enzyme but increases the 
COX-1 activity, indicating the critical role of COX-1 in prostanoids generation. 
However, myotoxin III (MT-III), a phospholipase A2 (sPLA2) from Bothrops asper 
snake venom, not only induces the COX-2 expression but an increment in COX-1 
activity was also detected in the first hour of stimulation of macrophages (Moreira et 
al., 2008). In contrast, inflamin induces the COX-1 enzyme activity to peak at 10 min 
after the protein administration, which subsides gradually with time and later COX-2 
enzyme activity is noticed at 3 h due to induction of COX-2 expression by inflamin. 
COX isoforms catalyzes the conversion of arachidonic acid to PGH2, which is later 
converted to various prostanoids by terminal PG-synthases. Arachidonic acid can be 
either generated by PLA2 enzyme or DAG lipase (Dieter and Fitzke, 1993). The 
tremendous amount of increment in prostanoids convinced us to investigate the 
pathway through which arachidonic acid is being generated. Our results showed 
clearly that the treatment of macrophages with the cPLA2 inhibitor AACOCF3 
significantly reduced the production of 6-keto PGF1α at 10 min after inflamin 
administration (60% reduction). In contrast, inhibition of iPLA2 by PACOCF3, sPLA2 
by YM 26734 and DAG lipase by RHC 80267 did not alter 6-keto PGF1α production 
induced by inflamin upon 10 min incubation. These results clearly indicate that 
cPLA2 plays a major role in the prostanoids biosynthesis upon inflamin 
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administration. On the contrary, cPLA2 enzyme is not involved in the supply of 
arachidonate for prostanoids production induced by CB. Rather, CB requires iPLA2 
for the biosynthesis of arachidonate and PGD2. But, MT-III, like inflamin, depends 
upon cPLA2 enzyme for the supply of arachidonic acid (Moreira et al., 2008). On the 
other hand, phorbol 12-myristate 13-acetate (PMA), a phorbol ester, induces DAG 
lipase for the liberation of arachidonate from DAG. However, zymosan stimulates 
both DAG lipase and PLA2 enzyme for the production of arachidonate (Dieter and 
Fitzke, 1993).       
The cPLA2 activity increases by 62% within 10 min of inflamin administration which 
confirms the role of cPLA2 in prostanoids biosynthesis. Expression of cPLA2 did not 
change but our results clearly show that the enzyme was phosphorylated at Ser505 
within minutes after the inflamin administration. Previously, it has been reported that 
the full activation of cPLA2 enzyme occurs when the enzyme, depending on the 
stimulus and cell type, is phosphorylated at Ser505 by MAP kinases (Lin et al., 1993; 
Borsch-Haubold et al., 1999). Therefore, we speculate that MAP kinases 
phosphorylate cPLA2 enzyme at Ser505 on inflamin administration which results in an 
increase in its activity. Another study reveals that phosphorylation at Ser505 increases 
the affinity of cPLA2 enzyme towards phospholipids at low Ca2+ concentration (Das 
et al., 2003). Thus, inflamin induces the increase in cPLA2 activity by 
phosphorylation at Ser505, which in turn increases the rate of arachidonate 








We have functionally characterized and delineated the mechanism of action of 
inflamin, a novel protein from Aipysurus eydouxii snake. Inflamin induced edema and 
writhing in experimental animals which is an indication of inflammation and pain. 
The estimation of prostanoids produced in the peritoneal cavity following inflamin 
injection revealed two waves of prostanoids production; rapid first wave at 10 min 
and gradually increasing second wave at 2 h. The increase in 6-keto PGF1α level was 
highest among all the prostanoids at 10 min which suggests that the PGH2 liberated by 
cyclooxygenase enzyme is shunted towards prostacyclin synthase. Our results 
revealed that COX-1 enzyme is responsible for the first wave of prostanoids 
production but later COX-2 is induced which marks the onset of second wave of 
prostanoids production. Further investigation showed that cPLA2 enzyme is activated 
by phosphorylation at Ser505 residue within minutes after the administration of 




































Structural characterization of inflamin 
4.1 Introduction  
As stated previously, inflamin has a unique sequence which does not show any 
similarity with proteins in the database. Thus, it is very important to delineate the 
structure of inflamin and to map the disulfide bonds. The deduced structure of 
inflamin may help in investigating the structure-function relationship. To determine 
the secondary structure of inflamin, ultra-violet (UV) circular dichroism (CD) 
spectroscopy was used. CD is the difference in the absorption of left-handed polarized 
light and right-handed polarized light which arise due to structural asymmetry.  
Inflamin is composed of 94 amino acid residues including six cysteines cross-linked 
by three disulfide bonds. To determine the disulfide linkage, proteolytic cleavage and 
mass spectrometry analysis was considered initially. But since inflamin contains no 
suitable protease cleavage sites between the cysteine residues, an alternative strategy 
of partial reduction and cyanylation was employed to determine the cysteine 
connectivity. Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), a water soluble 
reducing agent, was used for partial reduction of inflamin and the reaction was 
optimized with respect to incubation time and temperature to yield the highest ratio of 
partially reduced disulfide species relative to fully reduced species. The cyanylation 
of thiol groups was done using 1-cyano-4-dimethylaminopyridinium (CDAP) at 
acidic conditions. It is advantageous to use TCEP and CDAP as reducing and 
cyanylating agent respectively, as they are compatible with acidic pH, thus 
minimizing disulfide shuffling (Vila-Perelló and Andreu, 2005).  
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One of the two techniques that can be used for determining the three-dimensional 
(3D) structure of a protein is X-ray crystallography. In simple words, X-ray 
diffraction is analogous to a very high power microscope that can assist us in 
visualization of protein structure at a great molecular detail. It is possible as the 
wavelength of X-ray used for diffraction is typically the same order of magnitude as 
the spacing d between the planes in the crystal. When a beam of X-ray strikes a 
crystal then it is scattered into many specific directions. This is solely based on the 
fact that electrons in the atoms forming the crystal can diffract X-rays and hence 
produce a specific diffraction pattern. From the angles and intensities of these 
diffracted beams, a three-dimensional electron density map of the molecule can be 
created. Using this electron density map, the mean positions of the atoms in the 
crystal can be determined. The quality of the protein crystal obtained is very 
important for the successful determination of the three-dimensional structure of the 
protein. Thus, the aim of protein crystallization is to obtain well-ordered protein 
mono-crystals large enough to obtain a high resolution diffraction data. Unfortunately, 
each protein responds differently to the crystallization conditions and there are no 
standard protocols of crystallizing a protein. To identify the condition that can 
generate protein crystals, several crystallization conditions are screened initially. 
Later, the conditions can be optimized to obtain diffraction quality crystals.      
Thus, this chapter focuses on the secondary structure analysis and disulfide linkage 
determination of inflamin protein. Several attempts to crystallize the protein were 





4.2 Materials and Methods 
4.2.1 Materials 
Acetonitrile and trifluoroacetic acid solvents were purchased from Merck KGaA 
(Darmstadt, Germany). RP-Jupiter C18 (5 µ, 300 Å, 4.6 mm X 250 mm) column was 
purchased from Phenomenex (Torrance, CA, USA). TCEP was purchased from 
Invitrogen (Carlsbad, CA, USA). CDAP and α-cyano-4-hydroxycinnamic acid 
(CHCA) was purchased from Sigma-Aldrich (St. Louis, MO, USA). All the 
crystallization screens, crystallization trays, coverslips and grease were purchased 
from Hampton Research (Aliso Viejo, CA, USA). All other chemicals and reagents 
used were of analytical grade.  
 
4.2.2 Circular dichroism (CD) spectroscopy 
Far-UV CD spectra (260-190 nm) were recorded using a Jasco J-810 
spectropolarimeter (Jasco Corporation, Tokyo, Japan) as described previously 
(Rajagopalan et al., 2007). The protein sample (concentration 0.25 mg/ml) was 
dissolved in 5 mM phosphate buffer (pH 7.5) and placed in a cuvette with 0.1 cm 
pathlength. The cuvette chamber and instrument optics were continuously purged 
with nitrogen before and during the recording of the spectra to provide an oxygen-free 
environment. The spectra were recorded using a scanning speed of 50 nm/min, a data 
pitch of 0.1 nm and a bandwidth of 1 nm. An average of three scans was taken to 
increase the signal to noise ratio and the baseline was subtracted with the blank. The 





4.2.3 Disulfide linkage determination 
Partial reduction and cyanylation was employed to determine the disulfide linkage. 
Inflamin (20 nmol) was dissolved in 10 µl of 0.1 M citrate buffer (pH 3.0) containing 
6 M GnHCl. Partial reduction of inflamin was performed by incubating it with 60 
nmol of Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) in 0.1 M citrate buffer 
(pH 3.0) at 25ºC for 45 min. After cooling down to room temperature, 20-fold molar 
excess (over total cysteine content) of freshly prepared 0.1 M 1-cyano-4-
dimethylaminopyridinium (CDAP) in 0.1 M citrate buffer, pH 3.0, was added to the 
mixture and cyanylation was accomplished by incubation for 15 min at room 
temperature. The partially reduced and cyanylated species were purified by RP-HPLC 
using a Jupiter C18 column and molecular weight was determined by API-300 
LC/MS/MS system as described previously. Singly reduced and cyanylated protein 
species were reconstituted in 20 µl of 1 M NH4OH containing 6 M GnHCl and 
subsequently 50 µl of 1 M NH4OH solution was added. This reaction mixture was 
incubated for 1 h at room temperature which was followed by removal of excess 
ammonia by Speed Vac. After cleavage, the fragments were reduced completely using 
50 µl of 0.1 M TCEP for 30 min at 37ºC. The samples were diluted 50 times with 
50% acetonitrile containing 0.1% TFA and spotted onto the MALDI sample plate. 
The sample solution (0.3 µl) was mixed with the equal volume of α-cyano-4-
hydroxycinnamic acid (CHCA) matrix solution on the target plate and allowed to dry 
at room temperature. Raw data was obtained on 4700 Proteomics Analyzer (Applied 






4.2.4 Crystallization of inflamin 
Crystallization conditions for inflamin were screened with Hampton Research screens 
(Crystal Screen, Crystal Screen 2, Index, SaltRx, PEGRx 1, PEGRx 2, PEG/Ion, 
PEG/Ion 2, Grid Screen Ammonium Sulfate and Grid Screen MPD) using a hanging-
drop vapour-diffusion method. The lyophilized protein was dissolved in 10 mM Tris-
HCl buffer pH 8.0. The protein concentrations used for setting the drops were 5 
mg/ml, 20 mg/ml and 30 mg/ml. The drops were prepared by mixing equal volume (1 
μl each) of protein and crystallization solutions. Each well was filled with 500 µl of 
respective reservoir solution (crystallization solution). The plates were set at 25ºC and 




4.3.1 Circular dichroism (CD) spectroscopy 
The secondary structure of inflamin was evaluated by CD spectroscopy analysis 
(Figure 4.1). The CD spectrum showed minima at 203 and 223 nm. Thus, the 
percentage of random coil, α-helix and β-sheet is 54%, 17% and 29%, respectively.  
 
4.3.2 Disulfide linkage determination 
To determine the disulfide connectivity in refolded inflamin, we used partial reduction 
and cyanylation method. Our initial experiments to reduce inflamin yielded either 
intact protein or fully reduced protein at different incubation time and temperature. 
This suggests that protein molecule might become more accessible for complete 
reduction after the disruption of initial few bonds. Thus, partial reduction of inflamin 
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by TCEP was optimized with respect to incubation time (45 min) and temperature 
(25ºC) to yield highest ratio of partially reduced to completely reduced protein 
species. The thiol group was cyanylated by CDAP at acidic conditions to minimize 
disulfide shuffling. The reduced and cyanylated protein species eluted after 
unmodified protein on RP-HPLC (Figure 4.2). Two peaks corresponding to singly 
reduced and cyanylated isomer had a mass of 13011.03 ± 0.38 Da (Figure 4.3) and 
13011.1 ± 0.46 Da (Figure 4.4) and a peak corresponding to doubly reduced and 
cyanylated species had a mass of 13063.04 ± 0.60 Da (Figure 4.5). Last peak was 
having a mass of completely reduced and cyanylated protein species (Figure 4.6), 
which cannot be used for the disulfide linkage determination.  
The lyophilized samples were cleaved by 1 M NH4OH followed by complete 
reduction of the samples to disrupt all the residual disulfide bonds using TCEP and 
then analyzed by MALDI-TOF (Figure 4.3, 4.4 and 4.5). The mass calculated for each 
of the possible cleaved fragments resulting from all possible singly reduced and 
cyanylated species were compared with the m/z signals from singly reduced and 
cyanylated isomers. On the basis of the unique masses of the fragments from singly 
reduced and cyanylated isomers, the disulfide bonding pattern was determined as I-III 
and II-IV. The doubly reduced and cyanylated species also showed I-III and II-IV 
disulfide linkage (Figure 4.7A). Due to unknown reason, singly reduced and 
cyanylated species for V-VI disulfide bond could not be obtained. But since inflamin 
has three disulfide bonds with two bonds (I-III and II-IV) already determined by 
partial reduction and cyanylation, the third disulfide bond is obviously V-VI. Thus, 






Figure 4.1 Far-UV CD spectrum of inflamin. Two minima at 203 and 223 nm are 
observed. The percentage of random coil, α-helix and β-sheet are 54%, 17% and 29%, 
respectively.   
 
 
Figure 4.2 RP-HPLC profile of partially reduced and cyanylated protein reaction 
mixture. P: Unmodified protein; TC1 and TC2: Singly reduced and cyanylated 
species; TC3: Doubly reduced and cyanylated species; TC4: Fully reduced and 




















   
   










   
   
















Figure 4.3 ESI-MS spectra of TC1 (Singly reduced and cyanylated protein species) showing six peaks of mass/charge (m/z) ratio ranging from 
+7 to +12 charges. The mass was determined to be 13011.03 ± 0.38 Da (inset). Following NH4OH cleavage and complete reduction by TCEP, 








































































Figure 4.4 ESI-MS spectra of TC2 (Singly reduced and cyanylated protein species) showing six peaks of mass/charge (m/z) ratio ranging from 
+7 to +12 charges. The mass was determined to be 13011.1 ± 0.46 Da (inset). Following NH4OH cleavage and complete reduction by TCEP, the 













































































Figure 4.5 ESI-MS spectra of TC3 (Doubly reduced and cyanylated protein species) showing seven peaks of mass/charge (m/z) ratio ranging 
from +7 to +13 charges. The mass was determined to be 13063.04 ± 0.60 Da (inset). Following NH4OH cleavage and complete reduction by 
TCEP, the fragments were analyzed by MALDI-TOF. The results on the right hand side of the picture show the molecular weight of three 















































































Figure 4.6 ESI-MS spectra of TC4 (Completely reduced and cyanylated protein 
species) showing seven peaks of mass/charge (m/z) ratio ranging from +7 to +13 
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4.3.3 Crystallization of inflamin 
Nearly 600 different conditions were set up for the crystallization of inflamin using 
three different concentrations (5 mg/ml, 20 mg/ml and 30 mg/ml) of protein. All the 
attempts made to get a crystal of the protein were unsuccessful. However, the 
concentration of the protein used for crystallization was sufficient because 


















Circular Dichroism (CD) spectroscopy is non-destructive, relatively easy technique 
and requires small amount of sample for preliminary structure analysis. Apart from it, 
data collection and analysis is quite fast. The CD spectrum reveals that the percentage 
of random coil, α-helix and β-sheet in inflamin molecule is 54%, 17% and 29%, 
respectively.  
Inflamin has six cysteines cross-linked by three disulfide bridges as determined by 
ESI-MS and corroborated by Ellman assay. Initially, traditional method of enzyme 
digestion and mass spectrometry analysis was considered to determine the disulfide 
bridges. But, inflamin contains no suitable protease cleavage sites between the 
cysteine residues. So, partial reduction and cyanylation method was employed for 
mapping disulfide linkage. The partial reduction of inflamin was done by TCEP, a 
water soluble reducing agent, and cyanylation of thiol groups was carried out using 
CDAP at acidic conditions to minimize disulfide shuffling. Two peaks corresponding 
to singly reduced and cyanylated isoforms were identified by RP-HPLC. However, a 
peak corresponding to the third singly reduced and cyanylated inflamin isomer was 
not found due to unknown reasons. But since two (I-III and II-IV) of the three 
disulfide bonds were determined, the third disulfide bond is undoubtedly V-VI. Thus, 
the disulfide bonding pattern in inflamin protein was determined to be I-III, II-IV and 
V-VI.  
The three-dimensional (3D) structure of inflamin can be determined by X-ray 
crystallography. But, serious attempts to crystallize the protein were unsuccessful. It 
would have been a great achievement to determine the 3D structure of inflamin as it is 
a novel protein.  
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4.5 Conclusion  
The preliminary secondary structure analysis of inflamin was done by circular 
dichroism. The percentage of random coil, α-helix and β-sheet in inflamin molecule is 
54%, 17% and 29%, respectively. The disulfide linkage determination was performed 
using partial reduction and cyanylation method. The most important advantage of this 
method is compatibility of the reagents with acidic conditions. Inflamin has I-III, II-
IV and V-VI disulfide bonds. Attempts to crystallize inflamin protein were 




































Conclusions and future perspectives 
5.1 Conclusions  
This thesis reports the expression and characterization of a novel protein inflamin, 
which was first identified from the cDNA library of the venom gland tissue of 
Aipysurus eydouxii snake.  Inflamin is composed of 94 amino acid residues including 
6 cysteine residues and showed no sequence similarity with any protein in the 
database. Thus, we were interested in characterizing what could be a new family of 
snake venom proteins. 
For the detailed structural and functional characterization, inflamin was 
recombinantly expressed in E. coli system and purified by Ni-NTA affinity 
chromatography. Inflamin was reduced using DTT followed by RP-HPLC 
purification. Subsequently, protein was subjected to refolding using a redox system 
followed by running RP-HPLC to separate different conformers of inflamin. The 
homogeneity of the sample and formation of three disulfide bonds was confirmed by 
ESI-MS.  
The activity of inflamin was tested by in vivo and in vitro methods. Inflamin was 
found to be weakly hemolytic. When injected into mice at doses 10 mg/kg, 50 mg/kg 
and 100 mg/kg, all of them showed writhing responses but none of the mice died 
within 24 h. This indicated that inflamin is non-toxic and induces writhing, which is a 
pharmacological symptom of pain. The frequency of writhing reactions peaked during 
5-10 min period. Dose-dependent increase in writhing responses, subdued by 
indomethacin pre-treatment, was observed. Also, the time- and dose-dependent 
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increase in edema was observed until 2 h followed by gradual decrease in edema. 
These findings clearly indicate that inflamin induces inflammation leading to pain in 
experimental animals.   
The estimation of prostanoids produced in the peritoneal cavity following inflamin 
injection revealed two waves of prostanoids production; rapid first wave at 10 min 
and gradually increasing second wave at 2 h. As expected, the levels of prostanoids 
peaked at 10 min after injection which corresponded well to the peak of writhing 
responses. Interestingly, the increase in 6-keto PGF1α level was highest among all the 
prostanoids at 10 min indicating that most of the PGH2 liberated by cyclooxygenase 
enzyme is shunted towards prostacyclin synthase enzyme, which liberates PGI2. 
Further investigation showed that COX-1 activity increased at 10 min following 
inflamin administration but COX-1 expression was not affected. However, COX-2 
expression and enzymatic activity was induced only at 3 h. Taking all these findings 
together, COX-1  is responsible for the first wave of prostanoids production but later 
COX-2 is induced which marks the onset of second wave of prostanoids production.  
To examine the mechanism of arachidonate generation, inhibitors of PLA2 and DAG 
lipase were used. AACOCF3, an inhibitor of cPLA2 enzyme, significantly reduced 6-
keto PGF1α production induced by inflamin, indicating cPLA2 plays a major role in 
the prostanoids biosynthesis. Further investigation showed that cPLA2 enzyme is 
activated by phosphorylation at Ser505 residue within minutes after the administration 
of inflamin which ultimately leads to the biosynthesis of prostanoids, specifically 6-
keto PGF1α. 
The CD spectrum of inflamin showed minima at 203 and 223 nm. The percentage of 
random coil, α-helix and β-sheet was predicted to be 54%, 17% and 29%, 
113 
 
respectively. Inflamin has I-III, II-IV and V-VI disulfide bonds as determined by 
partial reduction and cyanylation method. Attempts were made to crystallize inflamin 
protein using three different concentrations but unfortunately, we could not get a 
crystal.  
So far, we named new families of snake venom toxins based on their structure. For 
example, helveprins for their similarity to helothermine (Kini et al., 2001, 
subsequently named as CRISPs, Yamazaki and Morita, 2004), waprins for their 
similarity to whey acidic proteins (Torres et al., 2003), vespryns for their similarity to 
PRY/SPRY domain proteins (Pung et al., 2005) and veficolins for their similarity to 
ficolins (Ompraba et al., 2010). As inflamin did not have similarity to any proteins in 
the database, we name this new family of snake venom proteins as ‘flamins’. 
Overall, we have expressed and functionally characterized a novel protein inflamin 
inducing inflammation and pain. This is the first report of a snake toxin inducing 
cPLA2 phosphorylation which leads to increase in its activity.      
 
5.2 Future perspectives 
This thesis mainly covers the functional characterization of a novel protein inflamin 
from Aipysurus eydouxii snake. Inflamin induces cPLA2 phosphorylation leading to 
increase in its activity followed by prostanoids biosynthesis. Although we speculate 
that MAPK phosphorylates cPLA2 enzyme, upstream events that signal the cPLA2 
phosphorylation are still unknown. More importantly, the receptor to which inflamin 
binds to and initiates the signaling cascade is not identified. Thus, future work needs 
to be done to delineate the detailed mechanism of cPLA2 phosphorylation. Apart from 
it, the three-dimensional structure (3D) of inflamin needs to be determined as it is a 
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novel protein molecule. This will improve our basic understanding towards inflamin. 
In future, inflamin may also be useful as a molecular research tool in the investigation 
of inflammation. 
 
5.2.1 Identification of receptor   
The receptor identification can help us to understand the mechanism of action in 
detail. To identify the receptor that interacts with inflamin and initiates the signaling 
cascade, receptor pull-down assay can be done by exploiting a strong non-covalent 
interaction between biotin and streptavidin. Inflamin can be preferentially labeled 
with biotin group at N-terminal of the protein at pH 6.5 using optimized ratio of 
protein to biotin. Streptavidin beads can be incubated with biotinylated inflamin 
followed by addition of cell membrane preparation. After washing thoroughly, the 
eluted protein-protein complex can be run on SDS-PAGE. The receptor can be 
identified by peptide mass fingerprinting (PMF). We can confirm the interaction 
between inflamin and receptor by using an antagonist, if available, of that particular 
receptor.  
 
5.2.2 Biophysical studies of inflamin 
Once the receptor is identified, we can determine the binding affinity of inflamin 
towards the receptor by surface plasmon resonance (SPR), which utilizes biosensors 
to measure the change in the refractive index of the solvent near the surface of the 
sensor that happens during the association and dissociation of complex. The analysis 
occurs in real time that enables association and dissociation rates to be measured for 
the determination of affinity and kinetics. Thus, we can immobilize the receptor on 
the chip and monitor its interaction with inflamin protein in solution. Since some 
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membrane receptors are insoluble, we can use a method based on capture of 
detergent-solubilized receptor prior to their reconstitution in a lipid environment 
(Navratilova et al., 2005). Thus, this experiment will shed some light on the affinity 
and kinetics of the interaction between inflamin and receptor.  
 
5.2.3 Structure-function relationship of inflamin 
Inflamin interacts with a yet-to-be identified receptor and subsequently initiates a 
signaling cascade which results in inflammation. The functional site in inflamin 
protein which is responsible for its interaction with the receptor is unknown. Thus, it 
would be interesting to determine the functional site in the protein which can 
subsequently help us to design a peptide showing similar effect. We can truncate the 
protein to get rid of the third disulfide bond at the C-terminal and determine whether 
it retains the activity. Depending upon the results, we can further truncate few 
residues from N-terminal and determine its effect. This truncated protein, if found to 
be active, can also be used for receptor pull down assay. Therefore, determining the 
functional site in inflamin is important and worth examining.  
 
5.2.4 Structural determination of inflamin 
It would be really interesting to determine the 3D structure of inflamin protein as it is 
a novel protein with no sequence similarity. The functionally active truncated protein 
can be used for crystallization. If protein crystals are not obtained then nuclear 
magnetic resonance (NMR) can be used to determine its structure. For three-
dimensional structure determination by NMR, 15N- and 13C-labeled protein needs to 
be expressed and purified. Before doing 3D NMR experiments, heteronuclear single 
quantum correlation (HSQC) (2D NMR) of the protein sample is taken to check the 
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peak dispersion. The labor-intensive process of structure determination is undertaken 
when peaks in HSQC are well-dispersed and number of peaks are almost equal to the 
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Figure A.1 Open reading frame of inflamin protein. Putative signal peptide is 
highlighted in bold. Stop codon is labeled as asterisk.  
 
 




Volume / Amount for 2 Gels (ml) 
12/15% Resolving 
Gel  4% Stacking Gel  
Milli Q  3.4/2.4  3.05  
30% Acrylamide Mix  4.0/5.0  0.85  
Resolving Gel Buffer 
(1.5 M Tris pH 8.8)  
2.5/2.5  -  
Stacking Gel Buffer 
(0.5 M Tris pH 6.8)  
-  1.25  
10% SDS  0.1/0.1 0.05  
10% APS (Freshly 
Prepared)  
0.05/0.05  0.05  












Figure A.2 Vector map of pET-32a and pET-M. pET-32a was engineered to 
remove thioredoxin tag and S-tag (shown in gray boxes) while retaining the His-tag 
and multiple cloning site (MCS). It was named as pET-M vector. 
 
 
 
 
